US20020016611A1 - Device and method for facilitating hemostasis of a biopsy tract - Google Patents
Device and method for facilitating hemostasis of a biopsy tract Download PDFInfo
- Publication number
- US20020016611A1 US20020016611A1 US09/953,395 US95339501A US2002016611A1 US 20020016611 A1 US20020016611 A1 US 20020016611A1 US 95339501 A US95339501 A US 95339501A US 2002016611 A1 US2002016611 A1 US 2002016611A1
- Authority
- US
- United States
- Prior art keywords
- pledget
- adaptor
- sponge
- biopsy
- cannula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00654—Type of implements entirely comprised between the two sides of the opening
Definitions
- the invention relates to a wound closure device, and more particularly, the invention relates to a device and method for facilitating hemostasis of a biopsy tract or other puncture wound by injection of an absorbable sponge.
- Percutaneous needle biopsy of solid organs is one of the most common interventional medical procedures. Millions of percutaneous needle biopsies are performed annually in the United States and throughout the world. Percutaneous biopsy is a safe procedure which has supplanted surgical biopsy for many indications, such as skin biopsy and liver biopsy.
- Possible complications of needle biopsy include bleeding at the biopsy site.
- the amount of bleeding is related to a number of factors including needle size, tissue sample size, patient's coagulation status, and the location of the biopsy site.
- Vascular organs such as the liver, a common biopsy target, may bleed significantly after needle biopsy.
- small-gauge needles are typically used. Small gauge needles, however, produce less satisfactory biopsy specimens but frequently are favored over larger bored needles because of their perceived safety.
- external pressure is applied and patients are often asked to lie in uncomfortable positions, such as the lateral decubitus position, for a number of hours, particularly after liver biopsy.
- Sterile sponges such as Gelfoam
- the sponge sheets are left in the surgical site after surgery to stop bleeding and are absorbed by the body in 1 to 6 weeks.
- a number of techniques have used these absorbable sterile sponge materials to plug a biopsy tract to minimize or prevent bleeding.
- the absorbable sponge provides a mechanical blockage of the tract, encourages clotting, and minimizes bleeding though the biopsy tract.
- this technique has not achieved widespread use because of difficulty in preparing and delivering the sponge material into the biopsy tract.
- U.S. Pat. No. 5,388,588 One example of a biopsy wound closure device using an implantable sponge is described in U.S. Pat. No. 5,388,588.
- a circular sponge of an absorbable foam material is precut and inserted into a biopsy site by an applicator rod having the sponge positioned on the end. Once the sponge is implanted, the sponge absorbs blood and swells to fill the tract preventing further bleeding at the biopsy site.
- the sponge is difficult to deliver and expands slowly once delivered.
- this delivery method can only deliver a sponge of a limited size which provides less local compression than desired and may incompletely fill the target site. Further, bleeding may continue along sections of the biopsy tract where no sponge has been delivered.
- the present invention relates to a device and method for facilitating hemostasis of a biopsy tract or other puncture wound by injecting an absorbable sponge.
- the system according to the present invention allows the sponge to be delivered in a hydrated state through the biopsy needle or other cannula directly into the puncture wound.
- a system for injecting a sponge into tissue includes a pledget of sponge having a proximal end with a larger cross sectional area than a distal end, a cannula for delivering the pledget in a hydrated state to the tissue, and an adaptor connectable to the cannula for hydrating and delivering the pledget to the cannula, the adapter having a tapered lumen with a large diameter proximal end and a small diameter distal end, wherein the small diameter distal end is connectable to the cannula.
- a method of forming a sponge pledget for delivery to tissue includes steps of cutting a strip of sponge from a sheet of sponge material and folding the strip to form a pledget with a first end having a first cross sectional area and a second folded end having a second cross sectional area which is larger than the first cross sectional area.
- a system for preparing and delivering a hydrated sponge to a cannula for delivery to tissue includes an adaptor and a template.
- the adaptor includes an elongated member having a first end, a second end, and a lumen extending from the first end to the second end, a luer connector provided at the second end for connection to a cannula, a tapered section of the lumen tapering from a first diameter at the first end to a second diameter at the second end which is smaller than the first diameter such that a dry sponge pledget having a width larger than the second diameter is compressible when hydrated to allow passage of the pledget into the second diameter.
- the template is configured for use in cutting the sponge to a size to be received in the elongated member for delivery to the cannula.
- an adaptor system for delivering a hydrated sponge to a cannula for delivery to tissue includes an elongated adaptor having a distal end, a proximal end, a lumen tapering from a larger diameter at a proximal end to a smaller diameter at the distal end, and a luer connection at the distal end, and a removable vent cap configured to engage the luer connection, the vent cap having a vent hole which allows fluid to pass out of the adaptor through the cap but prevents the sponge from passing through the vent hole.
- a method of delivering a sponge into a tissue access tract includes the steps of delivering a hydrated sponge pledget through a cannula positioned in a tissue access tract at a velocity E while withdrawing the cannula from the tissue at a velocity V to deposit the sponge pledget and seal the tissue access tract, wherein the velocity E is greater than or equal to the velocity V.
- FIG. 1 is a perspective view of a punch for forming pledgets
- FIG. 2 is a side cross sectional view of an adaptor for delivery of a pledget to a needle
- FIG. 3 is a side cross sectional view of a syringe for connection to the adaptor
- FIG. 4 is a side cross sectional view of an adaptor and syringe combination with a pledget positioned within the adaptor;
- FIG. 5 is a side cross sectional view of an adaptor and syringe combination in accordance with an alternative embodiment in which the pledget has been hydrated and moved into a small diameter end of the adaptor;
- FIG. 6 is a side cross sectional view of the loaded adaptor and syringe combination in preparation for connection to a biopsy needle;
- FIG. 7 is a side cross sectional view of an alternative embodiment of an adaptor connected to a biopsy needle and syringe;
- FIG. 8 is a side cross sectional view of an alternative embodiment of an adaptor
- FIG. 9 is a side cross sectional view of an alternative embodiment of an adaptor with enlargements in the lumen for kneading the pledget;
- FIG. 10 is a side cross sectional view of an alternative embodiment of an adaptor with irregularities in the lumen for kneading the pledget;
- FIG. 11 is a side cross sectional view of an alternative embodiment of an adaptor for delivery of a pledget including a template attached to the adaptor;
- FIG. 12 is a bottom view of the adaptor and template of FIG. 11;
- FIG. 13 is a top view of the template as it is used for cutting a pledget from an absorbable sponge sheet
- FIG. 14 is a side cross sectional view of a distal end of an adaptor with a vent cap attached;
- FIG. 15 is a side cross sectional view of the adaptor and vent cap of FIG. 14 having a pledget staged within the adaptor;
- FIG. 16 is a side cross sectional view of a portion of an organ and a system for delivering a pledget into a biopsy tract in the organ.
- the system of the present invention delivers an absorbable sponge material in a hydrated state to facilitate hemostasis of a biopsy tract or other puncture wound in a simple and safe manner.
- the apparatus for delivering a hydrated absorbable sponge will be described below in connection with treatment of a biopsy tract after a percutaneous needle biopsy.
- the invention may be used for facilitating hemostasis of other types of puncture wounds or tissue access tracts to prevent bleeding of these wounds.
- the system for facilitating hemostasis of the biopsy tract includes a punch 10 for cutting a pledget 18 of absorbable sponge material from a sheet of this material, an adaptor 12 for delivering the pledget to a biopsy needle 16 , and a syringe 14 for hydrating and injecting the pledget.
- the adaptor 12 allows a relatively large pledget of absorbable sponge material to be compressed and inserted into the biopsy tract in a hydrated state.
- the absorbable sponge material for use in facilitating hemostasis may be any absorbable sponge which is capable of deforming upon hydration to be delivered by fluid pressure rough a biopsy needle or other cannula.
- “Pledget” means a piece of absorbable sponge of a generally elongated shape having a size which allows injection in a hydrated state through a biopsy needle or other cannula.
- “Sponge” means a biocompatible material which is capable of being hydrated and is resiliently compressible in a hydrated state.
- the sponge is non-immunogenic and may be absorbable or non-absorbable.
- “Absorbable sponge” means sponge which when implanted within a human or other mammalian body is absorbed by the body.
- “Hydrate” means to partially or fully saturate with a fluid, such as, saline, water, contrast agent, thrombin, therapeutic agent, or the like.
- “Kneading” of the absorbable sponge material means both dry and wet manipulation of sponge material which compresses, enlarges, or changes the shape of the sponge material causing the sponge material to have improved expansion response.
- FIG. 1 illustrates one example of a punch 10 , also called a dye cutter, for cutting an absorbable sponge sheet 20 into pledgets 18 of an appropriate size for delivery to a biopsy tract.
- the punch 10 includes a rectangular blade 22 fixed to a plate 24 having a handle 26 .
- the punch 10 is pressed down onto a flat sheet 20 of commercially available absorbable sponge to cut the pledget 18 of an appropriate size.
- other cutting devices such as, a scissor type hand punch, an automatic punching machine, or a templet and knife may be used for preparation of the pledget 18 .
- An alternative pledget forming system will be discussed in further detail below with respect to FIGS. 11 - 13 .
- FIG. 2 shows the adaptor 12 according to the present invention in which the pledget 18 is placed for hydration and for delivery through the biopsy needle 16 .
- the adaptor 12 allows pieces of absorbable sponge material with relatively large cross sections to be easily delivered through a biopsy needle 16 with a much smaller cross section.
- the adaptor 12 also functions to remove air from the pledget 18 .
- the adaptor 12 which delivers the hydrated pledget 18 to the needle 16 includes a first end 30 having an annular lip 32 or female luer fitting for connection to the syringe 14 .
- a second end 34 of the adaptor 12 has a male luer fitting 36 for connection to a biopsy needle 16 or other cannula.
- the luer fitting 36 includes a tapered external surface 38 and a retaining ring 40 with internal threads for receiving an annular lip of the biopsy needle.
- the adaptor 12 has an internal lumen with a first diameter D 1 at the first end 30 and a second diameter D 2 at the second end 34 . Between the first and second ends of the adaptor 12 a tapered section 42 of the adaptor provides a funnel for compressing the hydrated pledget 18 prior to injection through the biopsy needle 16 and needle hub 28 .
- the adaptor 12 may be formed in any known manner such as by molding from a plastic material.
- the adaptor 12 is transparent so that the pledget 18 can be viewed through the adaptor and the user can visually monitor when the pledget is loaded within the adaptor and when the pledget has been delivered into the needle.
- the adaptor lumen may be provided with a friction reducing coating for improved delivery. The delivery fluid also reduces friction for improved delivery by wetting the exterior surface of the pledget 18 .
- the syringe 14 includes a male luer fitting 46 , a fluid chamber 48 , and a plunger 50 .
- the first end 30 of the adaptor 12 is connectable to the luer fitting 46 of the conventional syringe 14 .
- the syringe i 4 may be provided with a spring 52 for automatic filling of the syringe 14 with a predetermined volume of fluid.
- the syringe may include a threaded syringe plunger, as shown in FIG. 7, for accurate injection of small quantities of fluid.
- the syringe volume will vary depending on the amount of fluid needed for hydration and delivery of the pledget 18 through the biopsy needle 16 .
- a biopsy needle 16 for use with the present invention is preferably a coaxial biopsy needle, such as a bi-axial or a tri-axial biopsy needle.
- a co-axial biopsy needle includes an outer needle or cannula through which a tissue sample is removed with a tissue scoop or other biopsy instrument. Once the tissue sample has been removed, the outer cannula remains in the patient as illustrated in FIG. 6.
- the cannula for delivery of the sponge pledget has been described as a biopsy needle, the cannula may be a catheter, sheath, or any other type of cannula.
- FIG. 4 shows the loading and hydration of the pledget 18 within the adaptor 12 .
- a pledget 18 is cut as described above and placed within the adaptor 12 from the first end 30 of the adaptor.
- the syringe 14 is filled with a predetermined amount of fluid, such as saline, and is connected to the first end 30 of the adaptor 12 by the luer fitting 46 .
- the plunger 50 of the syringe 14 is then depressed slowly causing fluid to pass into the adaptor 12 , hydrating the pledget 18 , and filling the adaptor with a column of fluid.
- the user waits a few seconds once the fluid is injected into the adaptor 12 until the pledget 18 is adequately hydrated creating a lubricous surface on the pledget.
- the pledget 18 may expand within the adaptor to fill or nearly fill the lumen of the adaptor.
- the adaptor 12 with the pledget 18 hydrated within the proximal end is ready to inject the pledget into a biopsy tract to facilitate hemostasis within the biopsy tract.
- the adaptor 12 may be loaded prior to beginning the biopsy procedure.
- the outer sheath of the biopsy needle 16 through which the biopsy has been taken is maintained in place within the biopsy tract, as shown in FIG. 6.
- the biopsy needle 16 provides pre-established targeting of the delivery site for delivery of the absorbable sponge pledget 18 and eliminates the uncertainty of re-access.
- the luer fitting 36 of the adaptor 12 is connected to the biopsy needle hub 28 , as illustrated in FIG. 6.
- the biopsy needle 16 is withdrawn a short distance, such as about 1 to 20 mm, along the biopsy tract to provide space for the pledget 18 to be received in the biopsy tract. Additional fluid is then rapidly injected by the syringe to move the pledget 18 into the biopsy needle 16 .
- the adaptor lumen When the adaptor lumen has been blocked by the hydrated pledget 18 which has swelled within the adaptor, injection of additional fluid will push the pledget through the tapered section 42 of the adaptor. If the adaptor lumen has not been entirely blocked by the pledget 18 , the venturi effect will help draw the pledget through the tapered section 42 of the adaptor.
- the pledget 18 After the pledget 18 is moved to the biopsy needle 16 , the pledget 18 is then delivered from the needle 16 to the biopsy tract by rapid injection of additional fluid by the syringe 14 .
- the hydrated pledget 18 quickly expands upon delivery to fill the available space in the biopsy tract to facilitate hemostasis and provide localized compression.
- one example of a needle hub 28 has an interior diameter D 3 which is larger than the diameter D 2 at the distal end 36 of the adaptor 12 .
- the large internal diameter needle hub 28 allows the hydrated pledget 18 which has been compressed by the tapered section 42 of the adaptor to expand in the needle hub before being compressed again into the needle lumen. This compression and enlargement of the hydrated absorbable sponge material, does not adversely effect the pledget delivery and in fact improves the expansion response of some delivered sponge materials as will be discussed in further detail below.
- the needle hub 28 may be designed to have a inner diameter approximately the same as the inner diameter D 2 at the distal end 36 of the adaptor.
- the pledget 18 should be completely delivered into the biopsy tract by the fluid and only a minimal amount of extraneous fluid should be delivered.
- the pledget 18 once inside the needle, may be delivered with about 0.02 to 1.5 ml of fluid depending on the size of the needle 16 used. Injection of larger amounts of fluid may distend the biopsy tract or displace the pledget within the organ.
- a pledget 18 having a size of approximately 20 mm by 2 mm cut from a sheet of commercially available Gelfoam having a thickness of approximately 1.5 mm can be hydrated and injected through a standard 18 gauge, approximately 15 cm long biopsy needle with approximately 0.9 ml of fluid.
- An adaptor according to this example has a first diameter D 1 of about 0.38 cm, a second diameter D 2 of about 0.14 cm, a total length of about 3.80 cm, and a taper angle of about 45°. About 0.3 ml of fluid is injected slowly to hydrate the pledget 18 and fill the adaptor with a column of fluid.
- vent holes 44 extend through the side walls of the adapter 12 adjacent the second end 34 for venting fluid during loading of the pledget 18 .
- the user places a finger over the second end 34 of the adaptor 12 to prevent the pledget from exiting the adaptor.
- the plunger 50 of the syringe 14 is then depressed slowly causing fluid to pass into the adaptor 12 and hydrate the pledget.
- the user waits a few seconds once the fluid is injected into the adaptor 12 until the pledget 18 is hydrated.
- a removable cap may be used as an alternative to placement of a finger at the distal end of the adaptor 12 during advancement of the pledget 18 through the tapered section 42 .
- the vent holes 44 may be omitted and a screen or a cap having a screen may be used to allow fluid to pass through the screen while the screen prevents the pledget 18 from being ejected.
- a vent cap will be described in further detail below with respect to FIGS. 14 and 15.
- FIG. 7 An alternative embodiment of the delivery system is illustrated in FIG. 7 in which an adaptor 12 is provided with a pressure indicator 64 to monitor pledget injection.
- the pressure indicator 64 is removably attached at a luer fitting 66 provided on a side of the adaptor 12 .
- the pressure indicator 64 includes a pressure dome 68 movable from the convex shaped extended position illustrated in FIG. 7 to a flat position depending on the pressure inside the adaptor 12 .
- Internal pressure within the biopsy needle 16 , the adaptor 12 , and the syringe 14 will drop as the pledget 18 is extruded from the biopsy needle into the biopsy tract. This causes the pressure dome 68 to move from the convex position illustrated in FIG. 7 to a flat position, indicating that pledget delivery is complete.
- FIG. 8 illustrates an alternative embodiment of an adaptor 12 a in which the tapered section 42 a is shorter and more abrupt.
- the particular size and shape of the adaptor 12 a according to either FIG. 2 or FIG. 8 may vary depending on the size of biopsy needle, the tissue sample size, and the size of pasget to be delivered.
- One example of the adaptor 12 a of FIG. 8 for delivery of an absorbable sponge pledget 18 through an approximately 18 gauge biopsy needle has a first adaptor diameter D 1 of about 0.25 cm or greater, preferably about 0.30 to 0.80 cm and a second adaptor diameter D 2 of about 0.25 cm or less, preferably, about 0.05 to 0.23 cm.
- An angle made by a wall of the tapered section 42 a with a longitudinal axis of the adaptor 12 a may vary from about 5° to 90°, but is preferably between about 30° and 60°.
- the tapered section 42 a is illustrated with a substantially planar interior surface, when shown in cross section. However, the tapered section 42 a may also have a convex or concave surface in cross section.
- the dimensions described for the adaptor 12 a are appropriate for use with an approximately 18 gauge biopsy needle commonly used for liver biopsies. For some of the much larger biopsy needles or cannulas used for skin or breast biopsies the adaptor dimensions would be scaled up accordingly.
- FIG. 8 also shows a connector 70 for connecting the adaptor 12 to a syringe 14 when the proximal end of the adaptor is larger in diameter than the standard syringe fitting.
- the connector 70 includes a first end 72 for connection to the syringe 14 and a second end 74 for connection to the adaptor 12 .
- Gelfoam is a porous, pliable, cross-linked gelatin material and is available commercially in sheet form as pre-compressed or non-compressed sponge.
- the material may be provided preformed as a pledget 18 or may be cut with a punch 10 , or a stencil or template and knife to form a pledget as described above. Once hydrated, the pledget 18 can be easily compressed to fit into a lumen having a smaller cross sectional area than the original cross sectional area of the pledget.
- the kneading of the hydrated pledget 18 during delivery encourages air trapped within the Gelfoam to be expelled and replaced with fluid, allowing rapid expansion upon delivery.
- a pledget 18 of a pre-compressed Gelfoam is hydrated and kneaded (expelling air) during delivery
- the pledget will have the absorbtion capacity to rapidly expand to many times (e.g., 3 or more times) its original dry volume upon delivery.
- a pledget 18 of the non-compressed Gelfoam is hydrated and kneaded (expelling air) during delivery, the pledget will have the absorbtion capacity to rapidly expand to its original dry volume upon delivery.
- the adaptor 12 b of FIG. 9 includes two enlarged areas 72 of the lumen. As the absorbable sponge pledget 18 passes through the lumen of the adaptor 12 b the material expands and is compressed by the adaptor to increase kneading of the pledget.
- FIG. 10 illustrates another alternative embodiment of the adaptor 12 c including a lumen with a plurality of staggered irregularities 74 for improved kneading of the absorbable sponge pledget 18 .
- the irregularities 74 will preferably have a relatively smooth surface to prevent the absorbable sponge material from becoming caught on the irregularities.
- FIG. 11 illustrates an alternative embodiment of an adaptor 112 with a pledget formation template 122 attached to the adaptor.
- the adaptor 112 includes a proximal end 130 having a female luer 132 and a distal end 134 having a male luer 136 .
- the pledget 118 is inserted in the proximal end 130 .
- a tapered section 142 is provided within the adaptor 112 for compressing the pledget 118 into the biopsy needle.
- Some devices and methods which allow the delivery of sponge material with a minimum amount of fluid include the use of the pledget configuration illustrated in FIG. 11, the use of a vent cap for staging of the pledget as illustrated in FIGS. 14 and 15, and the withdrawal of the biopsy needle during delivery as illustrated in FIG. 16.
- FIG. 11 illustrates a pledget 118 having a proximal cross sectional area which is approximately twice its distal cross sectional area.
- the smaller material mass at the distal end of the pledget 188 increases the ease of inserting the pledget into the adaptor 112 .
- the smaller distal end of the pledget also passes through the delivery cannula or biopsy needle without creating a large back pressure to resist the delivery of the pledget through the cannula.
- the larger proximal section of the pledget 118 provides a better seal within the interior of the adaptor 112 and the cannula 16 which allows a minimum amount of fluid to be used to advance the pledget.
- the increased material at the proximal end of the pledget 118 also increases the amount of sponge material delivered to the biopsy tract.
- Pledgets 118 with increased cross sectional area proximal ends may be prepared in a variety of manners. For example, if a pledget 118 is prepared from a sheet of sponge material, the increased proximal mass can be achieved by cutting the pledget with an enlarged proximal end. Alternatively, the pledget 118 may be formed by folding, rolling, compressing, or otherwise manipulating the sponge material to the desired shape. The proximal pledget mass may also be increased by adding separate pieces of material to the proximal end of the pledget. This additional material may be layered, wrapped, coiled or attached to the pledget in any other manner. The pledgets may also be formed by molding, bump extruding, dipping, or the like.
- the larger cross sectional area proximal end is generally about 1.2 to 4 times the cross sectional area of the distal end.
- the proximal end with the larger cross section area preferably extends along about 1 ⁇ 8 to 3 ⁇ 4 of the total pledget length.
- the pledget 118 illustrated in FIG. 11 has been formed by cutting a strip of material from an absorbable sponge sheet 20 with the aid of the template 122 as illustrated in FIG. 13. After the strip is cut, the proximal end of the strip is then folded back onto itself to form a pledget 118 with an increased cross sectional area and material mass at a proximal end.
- a Gelfoam pledget for delivery down a 20 gauge biopsy needle or cannula has a size of approximately 0.1 ⁇ 1.5 ⁇ 0.06 inches and is folded as illustrated in FIG. 11 to an overall length of about 0.9 inches.
- a pledget 118 in an adaptor 112 having a largest internal diameter of 0.125 inches allows the pledget to be delivered to a 20 gauge or larger biopsy needle.
- Other common biopsy procedures use an 18 gauge or larger biopsy needle through a slightly larger guide cannula and would receive a somewhat larger pledget.
- a pledget 118 maybe delivered through the cannula to the biopsy site.
- the pledget 118 for use in the system employing an 18 gauge or larger biopsy needle may be formed from a strip which is approximately 0.11-0.12 inches wide by about 3.125 inches long with a thickness of about 0.06 inches and folded to an overall length of about 2.2 inches. This pledget having a single thickness distal end and double thickness proximal end can be delivered from an adaptor having a largest internal diameter of approximately 0.125 inches.
- FIG. 13 One method for forming the pledget 118 with the enlarged proximal end with the aid of a template 122 is illustrated in FIG. 13.
- the template 122 is a flat plate having recesses 124 along one or more edges of the template.
- the recesses 124 have a width and a length which corresponds to a preferred width and length of the pledget.
- the recesses 124 form a raised bar 126 at a location where the pledget should be folded.
- the bar 126 makes an indentation or groove in the sponge material.
- a user cuts along the side 128 and end 129 edges of the template 122 with a blade to form a strip of the sponge material which is then folded along the groove or crease formed by the bar 126 to form the pledget 118 . It is important to securely hold the sponge sheet by applying downward pressure to the template 122 during cutting to prevent tearing and breaking of the sponge material. Prior to folding the strip of sponge material to form the pledget, the strip may be compressed with a flat surface of the template to compact the sponge and assist in loading the pledget into the adaptor 112 .
- the template 122 has been illustrated as a plate which is attached to the adaptor 112 , it should be understood that the template can also be a separate member.
- the template 122 may provide guides for forming pledgets of different sizes for delivery through different sized biopsy needles.
- the template 122 may be provided with or without the creasing bar 126 and may be transparent or opaque. In the opaque version, the edges of the recesses 124 are used to align the template with an edge of the sponge sheet 20 . In contrast, in a transparent version of the template, the recesses 124 may be eliminated and a visual indication or line may be provided which assists in aligning an edge of the sponge sheet with the template.
- FIGS. 14 and 15 illustrate a preferred vent cap 70 for use with the adapter 112 .
- vents maybe used to assist in hydrating and staging the pledget within the adapter.
- vents will allow the pledget to be moved to a preferred axial location within the adapter 112 prior to delivery.
- the vents allow fluid to be injected and air to be removed from the pledget prior to delivery.
- the vent cap 70 as illustrated in FIG. 14 includes a female luer connector 72 including a flange 74 which is received on the male luer 136 of the adapter 112 .
- the vent cap 70 also includes a conical portion 76 which is configured to extend into a distal end 134 of the adaptor 112 .
- the conical portion 76 has one or more fluid paths or vent holes 78 which allow air and fluid to exit through the vent cap but prevent the absorbable sponge material of the pledget 118 from passing through the vent cap.
- the vent hole may alternatively be positioned between the vent cap 70 and the adapter 112 .
- an exterior of the conical portion 76 forms a seal with the lumen of the adaptor 112 at the distal end.
- the diameter of the vent hole 78 is approximately 0.005-0.02 inches, preferably approximately 0.01 inches. This small vent hole 78 allows the purging and venting of fluid and air from the adapter 112 but does not allow the pledget 118 to pass through the venthole, even at high pressures such as 5 psi or greater.
- vent cap 70 allows the user to apply high pressures with the syringe used to hydrate the pledget.
- the high pressures drive the fluid into the pledget causing rapid and thorough hydration of the sponge material. Repeated pulsing of the fluid with the syringe will provide more complete hydration of the pledget.
- the vent cap 70 also positions the pledget 118 at a preferred axial position just proximal to the distal end 134 of the adapter 112 as illustrated in FIG. 15. This positioning of the pledget 118 away from the end of the adaptor prevents the pledget from becoming trapped between the adaptor 112 and the biopsy needle hub 28 which is attached to the distal end of the adaptor. In addition, after hydration of the pledget and removal of the vent cap 70 the sponge material may tend to swell out of the distal end of the adapter 112 . Accordingly, the conical portion 76 of the vent cap 70 preferably extends into the adaptor 112 approximately 0.01 to 0.1 inches, more preferably about 0.01 to 0.03 inches.
- the portion of the vent cap 70 which extends into the lumen of the adaptor 112 can be any desired shape such as dome-shaped, cylindrical, conical or other shape.
- the pledget maybe delivered to the biopsy tract by holding the biopsy needle or cannula 16 stationary and injecting the pledget through the biopsy needle. If additional pledgets are to be delivered, the biopsy needle 16 is withdrawn a distance sufficient to accommodate an additional pledget and the additional pledget is then injected.
- the method of delivering the pledget into the biopsy tract may include withdrawing the biopsy needle or cannula 16 during delivery of the pledget 18 to deliver the pledget in an elongated trail which follows the biopsy tract. Placing the absorbable sponge material in a trail which fills the entire biopsy tract provides the added benefit of providing hemostasis along the entire biopsy tract. This is particularly helpful for stopping the bleeding of biopsy tracts in organs which tend to have excessive bleeding such as the liver, kidney, spleen, and other vascular organs.
- one method of the present invention involves the delivery of the pledget into the biopsy needle by a predetermined amount of fluid.
- the biopsy needle is then withdrawn at a velocity V while the pledget material is ejected from the biopsy needle at a velocity E with respect to the biopsy needle.
- the velocity V at which the biopsy needle is withdrawn is equal to or less than the velocity E at which the absorbable sponge material is delivered.
- the control of injection of fluid and withdrawal of the needle to achieve the desired trail of absorbable sponge material in the biopsy tract maybe controlled with an injection controlling device.
- the adaptor maybe used to deliver the pledget into the biopsy needle 16 and then the adaptor is removed from the biopsy needle.
- a plunger or stylet 80 which is generally provided with the biopsy needle 16 for inserting the biopsy needle is then used to deliver the pledget from the biopsy needle.
- the biopsy needle extends through the tissue 84 and into the organ 86 for removal of a core of tissue.
- the pledget is injected into the needle 16 and the plunger 80 is placed within the biopsy needle so that a distal end of the plunger abuts the proximal end of the pledget 118 .
- the plunger 80 is then held stationary while the biopsy needle 16 is withdrawn from the biopsy site.
- the plunger 80 causes the pledget 118 to be delivered in a trail 88 which fills the biopsy tract.
- the trail 88 preferably extends along the entire biopsy tract to or past a surface of the organ 86 .
- the delivery of the trail 88 of absorbable sponge material provides an advantage over the delivery of discrete blobs of material because the trail is able to provide hemostasis along the entire tract.
- a blob of absorbable sponge material is delivered within the tract at a depth of 1-2 cm from the surface of the organs, this 1-2 cm of biopsy tract may continue to bleed significantly.
- the pledget may be delivered as a plug.
- the plunger 80 is advanced into the needle 16 pushing the pledget out of the distal end of the needle while the needle is held stationary.
- a combination of delivery of plugs and trails may also be used.
- the pledget material may be delivered entirely within a single anatomical structure or may cross two or more anatomical structures such as an organ, surrounding tissue and facial layer.
- non-absorbable sponge may also be delivered with the devices, systems, and methods of the present invention.
- a non-absorbable sponge may be desirable where it will be necessary to locate the biopsy site or tract after the procedure.
- the pledget 18 has been shown and described as having a rectangular cross section, pledgets of other shapes may also be used.
- the pledget may be preformed in any shape, such as with a rectangular or circular cross section or may be rolled from a thin sheet of absorbable sponge material.
- the pledget 18 may have a multi-sided cross section, a star shaped cross section, or a folded cross section and may have through or blind holes formed in the dry pledget.
- the pledget size and shape can be matched to the size and shape of a particular delivery site. Pledget shapes having greater surface area provided by features such as fins provide faster hydration.
- the continuous structure of the absorbable sponge pledget 18 provides more secure and reliable placement than a paste or liquid and can even facilitate partial withdrawal, removal, or movement of the delivered pledget.
- the biopsy needle 16 is retracted a distance sufficient to provide a space to accommodate an additional pledget 18 and the injection procedure described above is repeated for the additional pledget(s).
- additional pledgets 18 may be injected beside an initially injected pledget until the cavity is filled.
- biopsy is most commonly performed by biopsy needle, biopsy may also be performed through other cannulas, such as catheters, long needles, endoscopes, or the like.
- the treatment procedure according to the present invention can be used for facilitating hemostasis of puncture wounds through different types of cannulas including needles, catheters, endoscopes, and the like.
- the treatment procedure and systems according to the present invention may be used to deliver absorbable or non-absorbable sponge for other therapys.
- sponge may be delivered for cosmetic or reconstructive bulking or for temporary or permanent intravascular embolization.
- the absorbable sponge pledget 18 may be used to deliver a beneficial agent, such as contrast agent, thrombin, radiation treatment, or the like.
- the pledget can also be used to deliver therapeutic agents, such as radioactive isotopes for localized treatment of tumors, anti-cancer agents, anti-metastatic agents, and the like.
- therapeutic agents such as radioactive isotopes for localized treatment of tumors, anti-cancer agents, anti-metastatic agents, and the like.
- anticancer agents include 5-fluorouracil, cisplatin, prednisone, and others described in U.S. Pat. No. 4,619,913 which is incorporated herein by reference.
- the absorbable sponge pledget 18 may be presoaked with the beneficial agent for delivery to the biopsy tract.
- the pledget 18 may be hydrated with the beneficial liquid agent or the agent may be delivered to the pledget after the pledget is placed within the biopsy tract.
- a pledget formed of commercially available Gelfoam material will be absorbed by the body within 1 to 6 weeks.
- the pledget material may be designed to provide different rates of absorption.
- Gelfoam can be designed to be absorbed at different rates by varying the degree of cross-linking.
- the pledget is designed to be absorbed in less than one month.
- the treatment of a biopsy tract with a hydrated and injected pledget 18 of absorbable sponge to facilitate hemostasis provides substantial advantages in comfort over external pressure methods.
- the present invention also provides advantages over the insertion of an absorbable sponge material in a dry state with an applicator.
- the adaptor 12 allows a relatively large pledget to be compressed and inserted into the biopsy tract in a hydrated state.
- the injected pledget 18 conforms in shape quickly to the shape of the biopsy tract and immediately begins blocking blood flow.
- a dry piece of sponge material must be cut to the particular size of the biopsy tract and does not swell to fill the tract until the blood has sufficiently saturated the sponge material which can take significantly longer and provides inadequate local compression.
Abstract
Description
- This application is a continuation-in-part of U.S. application Ser. No. 09/071,670 filed May 1, 1998, which is incorporated herein by reference in its entirety.
- 1. Field of the Invention
- The invention relates to a wound closure device, and more particularly, the invention relates to a device and method for facilitating hemostasis of a biopsy tract or other puncture wound by injection of an absorbable sponge.
- 2. Brief Description of the Related Art
- Percutaneous needle biopsy of solid organs is one of the most common interventional medical procedures. Millions of percutaneous needle biopsies are performed annually in the United States and throughout the world. Percutaneous biopsy is a safe procedure which has supplanted surgical biopsy for many indications, such as skin biopsy and liver biopsy.
- Possible complications of needle biopsy include bleeding at the biopsy site. The amount of bleeding is related to a number of factors including needle size, tissue sample size, patient's coagulation status, and the location of the biopsy site. Vascular organs such as the liver, a common biopsy target, may bleed significantly after needle biopsy. To minimize bleeding from a biopsy site, small-gauge needles are typically used. Small gauge needles, however, produce less satisfactory biopsy specimens but frequently are favored over larger bored needles because of their perceived safety. In order to minimize the chance of internal bleeding after biopsy, external pressure is applied and patients are often asked to lie in uncomfortable positions, such as the lateral decubitus position, for a number of hours, particularly after liver biopsy.
- Sterile sponges, such as Gelfoam, are prepared in dry sterile sheets which are used as packing material during surgery for control of bleeding. The sponge sheets are left in the surgical site after surgery to stop bleeding and are absorbed by the body in 1 to 6 weeks. A number of techniques have used these absorbable sterile sponge materials to plug a biopsy tract to minimize or prevent bleeding. The absorbable sponge provides a mechanical blockage of the tract, encourages clotting, and minimizes bleeding though the biopsy tract. Despite the advantages of using absorbable sponge to plug a biopsy tract this technique has not achieved widespread use because of difficulty in preparing and delivering the sponge material into the biopsy tract.
- One example of a biopsy wound closure device using an implantable sponge is described in U.S. Pat. No. 5,388,588. According to this patent, a circular sponge of an absorbable foam material is precut and inserted into a biopsy site by an applicator rod having the sponge positioned on the end. Once the sponge is implanted, the sponge absorbs blood and swells to fill the tract preventing further bleeding at the biopsy site. However, the sponge is difficult to deliver and expands slowly once delivered. In addition, this delivery method can only deliver a sponge of a limited size which provides less local compression than desired and may incompletely fill the target site. Further, bleeding may continue along sections of the biopsy tract where no sponge has been delivered.
- Accordingly, it would be desirable to provide a device and method which will permit the delivery of an absorbable sponge to a biopsy tract in a simple and reliable manner.
- The present invention relates to a device and method for facilitating hemostasis of a biopsy tract or other puncture wound by injecting an absorbable sponge. The system according to the present invention allows the sponge to be delivered in a hydrated state through the biopsy needle or other cannula directly into the puncture wound.
- In accordance with one aspect of the present invention, a system for injecting a sponge into tissue includes a pledget of sponge having a proximal end with a larger cross sectional area than a distal end, a cannula for delivering the pledget in a hydrated state to the tissue, and an adaptor connectable to the cannula for hydrating and delivering the pledget to the cannula, the adapter having a tapered lumen with a large diameter proximal end and a small diameter distal end, wherein the small diameter distal end is connectable to the cannula.
- In accordance with an additional aspect of the present invention, a method of forming a sponge pledget for delivery to tissue includes steps of cutting a strip of sponge from a sheet of sponge material and folding the strip to form a pledget with a first end having a first cross sectional area and a second folded end having a second cross sectional area which is larger than the first cross sectional area.
- In accordance with a further aspect of the present invention, a system for preparing and delivering a hydrated sponge to a cannula for delivery to tissue includes an adaptor and a template. The adaptor includes an elongated member having a first end, a second end, and a lumen extending from the first end to the second end, a luer connector provided at the second end for connection to a cannula, a tapered section of the lumen tapering from a first diameter at the first end to a second diameter at the second end which is smaller than the first diameter such that a dry sponge pledget having a width larger than the second diameter is compressible when hydrated to allow passage of the pledget into the second diameter. The template is configured for use in cutting the sponge to a size to be received in the elongated member for delivery to the cannula.
- In accordance with an additional aspect of the invention, an adaptor system for delivering a hydrated sponge to a cannula for delivery to tissue includes an elongated adaptor having a distal end, a proximal end, a lumen tapering from a larger diameter at a proximal end to a smaller diameter at the distal end, and a luer connection at the distal end, and a removable vent cap configured to engage the luer connection, the vent cap having a vent hole which allows fluid to pass out of the adaptor through the cap but prevents the sponge from passing through the vent hole.
- In accordance with another aspect of the invention, a method of delivering a sponge into a tissue access tract includes the steps of delivering a hydrated sponge pledget through a cannula positioned in a tissue access tract at a velocity E while withdrawing the cannula from the tissue at a velocity V to deposit the sponge pledget and seal the tissue access tract, wherein the velocity E is greater than or equal to the velocity V.
- The invention will now be described in greater detail with reference to the preferred embodiments illustrated in the accompanying drawings, in which like elements bear like reference numerals, and wherein:
- FIG. 1 is a perspective view of a punch for forming pledgets;
- FIG. 2 is a side cross sectional view of an adaptor for delivery of a pledget to a needle;
- FIG. 3 is a side cross sectional view of a syringe for connection to the adaptor;
- FIG. 4 is a side cross sectional view of an adaptor and syringe combination with a pledget positioned within the adaptor;
- FIG. 5 is a side cross sectional view of an adaptor and syringe combination in accordance with an alternative embodiment in which the pledget has been hydrated and moved into a small diameter end of the adaptor;
- FIG. 6 is a side cross sectional view of the loaded adaptor and syringe combination in preparation for connection to a biopsy needle;
- FIG. 7 is a side cross sectional view of an alternative embodiment of an adaptor connected to a biopsy needle and syringe;
- FIG. 8 is a side cross sectional view of an alternative embodiment of an adaptor;
- FIG. 9 is a side cross sectional view of an alternative embodiment of an adaptor with enlargements in the lumen for kneading the pledget;
- FIG. 10 is a side cross sectional view of an alternative embodiment of an adaptor with irregularities in the lumen for kneading the pledget;
- FIG. 11 is a side cross sectional view of an alternative embodiment of an adaptor for delivery of a pledget including a template attached to the adaptor;
- FIG. 12 is a bottom view of the adaptor and template of FIG. 11;
- FIG. 13 is a top view of the template as it is used for cutting a pledget from an absorbable sponge sheet;
- FIG. 14 is a side cross sectional view of a distal end of an adaptor with a vent cap attached;
- FIG. 15 is a side cross sectional view of the adaptor and vent cap of FIG. 14 having a pledget staged within the adaptor; and
- FIG. 16 is a side cross sectional view of a portion of an organ and a system for delivering a pledget into a biopsy tract in the organ.
- The system of the present invention delivers an absorbable sponge material in a hydrated state to facilitate hemostasis of a biopsy tract or other puncture wound in a simple and safe manner. The apparatus for delivering a hydrated absorbable sponge will be described below in connection with treatment of a biopsy tract after a percutaneous needle biopsy. However, the invention may be used for facilitating hemostasis of other types of puncture wounds or tissue access tracts to prevent bleeding of these wounds.
- The system for facilitating hemostasis of the biopsy tract includes a
punch 10 for cutting apledget 18 of absorbable sponge material from a sheet of this material, anadaptor 12 for delivering the pledget to abiopsy needle 16, and asyringe 14 for hydrating and injecting the pledget. Theadaptor 12 allows a relatively large pledget of absorbable sponge material to be compressed and inserted into the biopsy tract in a hydrated state. The absorbable sponge material for use in facilitating hemostasis may be any absorbable sponge which is capable of deforming upon hydration to be delivered by fluid pressure rough a biopsy needle or other cannula. - Prior to discussing the present invention in further detail, the following terms are defined:
- “Pledget” means a piece of absorbable sponge of a generally elongated shape having a size which allows injection in a hydrated state through a biopsy needle or other cannula.
- “Sponge” means a biocompatible material which is capable of being hydrated and is resiliently compressible in a hydrated state. Preferably, the sponge is non-immunogenic and may be absorbable or non-absorbable.
- “Absorbable sponge” means sponge which when implanted within a human or other mammalian body is absorbed by the body.
- “Hydrate” means to partially or fully saturate with a fluid, such as, saline, water, contrast agent, thrombin, therapeutic agent, or the like.
- “Kneading” of the absorbable sponge material means both dry and wet manipulation of sponge material which compresses, enlarges, or changes the shape of the sponge material causing the sponge material to have improved expansion response.
- FIG. 1 illustrates one example of a
punch 10, also called a dye cutter, for cutting anabsorbable sponge sheet 20 intopledgets 18 of an appropriate size for delivery to a biopsy tract. Thepunch 10 includes arectangular blade 22 fixed to aplate 24 having ahandle 26. Thepunch 10 is pressed down onto aflat sheet 20 of commercially available absorbable sponge to cut thepledget 18 of an appropriate size. In addition to thepunch 10 illustrated in FIG. 1 other cutting devices, such as, a scissor type hand punch, an automatic punching machine, or a templet and knife may be used for preparation of thepledget 18. An alternative pledget forming system will be discussed in further detail below with respect to FIGS. 11-13. - FIG. 2 shows the
adaptor 12 according to the present invention in which thepledget 18 is placed for hydration and for delivery through thebiopsy needle 16. Theadaptor 12 allows pieces of absorbable sponge material with relatively large cross sections to be easily delivered through abiopsy needle 16 with a much smaller cross section. Theadaptor 12 also functions to remove air from thepledget 18. - The
adaptor 12 which delivers thehydrated pledget 18 to theneedle 16 includes afirst end 30 having anannular lip 32 or female luer fitting for connection to thesyringe 14. Asecond end 34 of theadaptor 12 has a male luer fitting 36 for connection to abiopsy needle 16 or other cannula. The luer fitting 36 includes a taperedexternal surface 38 and a retainingring 40 with internal threads for receiving an annular lip of the biopsy needle. Theadaptor 12 has an internal lumen with a first diameter D1 at thefirst end 30 and a second diameter D2 at thesecond end 34. Between the first and second ends of theadaptor 12 a taperedsection 42 of the adaptor provides a funnel for compressing thehydrated pledget 18 prior to injection through thebiopsy needle 16 andneedle hub 28. - The
adaptor 12 may be formed in any known manner such as by molding from a plastic material. Preferably, theadaptor 12 is transparent so that thepledget 18 can be viewed through the adaptor and the user can visually monitor when the pledget is loaded within the adaptor and when the pledget has been delivered into the needle. The adaptor lumen may be provided with a friction reducing coating for improved delivery. The delivery fluid also reduces friction for improved delivery by wetting the exterior surface of thepledget 18. - The
syringe 14 includes a male luer fitting 46, afluid chamber 48, and aplunger 50. Thefirst end 30 of theadaptor 12 is connectable to the luer fitting 46 of theconventional syringe 14. The syringe i4 may be provided with aspring 52 for automatic filling of thesyringe 14 with a predetermined volume of fluid. Alternatively, the syringe may include a threaded syringe plunger, as shown in FIG. 7, for accurate injection of small quantities of fluid. The syringe volume will vary depending on the amount of fluid needed for hydration and delivery of thepledget 18 through thebiopsy needle 16. - A
biopsy needle 16 for use with the present invention is preferably a coaxial biopsy needle, such as a bi-axial or a tri-axial biopsy needle. A co-axial biopsy needle includes an outer needle or cannula through which a tissue sample is removed with a tissue scoop or other biopsy instrument. Once the tissue sample has been removed, the outer cannula remains in the patient as illustrated in FIG. 6. Although the cannula for delivery of the sponge pledget has been described as a biopsy needle, the cannula may be a catheter, sheath, or any other type of cannula. - A preferred method of facilitating hemostasis of a biopsy tract will be described with reference to FIG. 4 which shows the loading and hydration of the
pledget 18 within theadaptor 12. Apledget 18 is cut as described above and placed within theadaptor 12 from thefirst end 30 of the adaptor. Thesyringe 14 is filled with a predetermined amount of fluid, such as saline, and is connected to thefirst end 30 of theadaptor 12 by theluer fitting 46. Theplunger 50 of thesyringe 14 is then depressed slowly causing fluid to pass into theadaptor 12, hydrating thepledget 18, and filling the adaptor with a column of fluid. Care should be taken to inject the fluid slowly to prevent the pledget from being ejected out of thesecond end 34 of the adaptor. Preferably, the user waits a few seconds once the fluid is injected into theadaptor 12 until thepledget 18 is adequately hydrated creating a lubricous surface on the pledget. Thepledget 18 may expand within the adaptor to fill or nearly fill the lumen of the adaptor. Theadaptor 12 with thepledget 18 hydrated within the proximal end is ready to inject the pledget into a biopsy tract to facilitate hemostasis within the biopsy tract. Theadaptor 12 may be loaded prior to beginning the biopsy procedure. - After the biopsy procedure has been completed, the outer sheath of the
biopsy needle 16 through which the biopsy has been taken is maintained in place within the biopsy tract, as shown in FIG. 6. Thebiopsy needle 16 provides pre-established targeting of the delivery site for delivery of theabsorbable sponge pledget 18 and eliminates the uncertainty of re-access. The luer fitting 36 of theadaptor 12 is connected to thebiopsy needle hub 28, as illustrated in FIG. 6. Thebiopsy needle 16 is withdrawn a short distance, such as about 1 to 20 mm, along the biopsy tract to provide space for thepledget 18 to be received in the biopsy tract. Additional fluid is then rapidly injected by the syringe to move thepledget 18 into thebiopsy needle 16. When the adaptor lumen has been blocked by thehydrated pledget 18 which has swelled within the adaptor, injection of additional fluid will push the pledget through the taperedsection 42 of the adaptor. If the adaptor lumen has not been entirely blocked by thepledget 18, the venturi effect will help draw the pledget through the taperedsection 42 of the adaptor. After thepledget 18 is moved to thebiopsy needle 16, thepledget 18 is then delivered from theneedle 16 to the biopsy tract by rapid injection of additional fluid by thesyringe 14. Thehydrated pledget 18 quickly expands upon delivery to fill the available space in the biopsy tract to facilitate hemostasis and provide localized compression. - As illustrated in the cross sectional view of FIG. 7, one example of a
needle hub 28 has an interior diameter D3 which is larger than the diameter D2 at thedistal end 36 of theadaptor 12. The large internaldiameter needle hub 28 allows thehydrated pledget 18 which has been compressed by the taperedsection 42 of the adaptor to expand in the needle hub before being compressed again into the needle lumen. This compression and enlargement of the hydrated absorbable sponge material, does not adversely effect the pledget delivery and in fact improves the expansion response of some delivered sponge materials as will be discussed in further detail below. - A smooth tapered transition between the lumen of the
needle hub 28 and the needle lumen helps to provide for easy injection of thepledget 18. However, needles having internal steps between theneedle hub 28 and theneedle 16 have been used and thepledget 18 is still injected successfully. According to an alternative embodiment of the invention, theneedle hub 28 may be designed to have a inner diameter approximately the same as the inner diameter D2 at thedistal end 36 of the adaptor. - Preferably, specific measured doses of fluid are used to achieve each of the steps of the treatment procedure depending on the pledget size and the dimensions of the
adaptor 12, theneedle 16, and theneedle hub 28. Thepledget 18 should be completely delivered into the biopsy tract by the fluid and only a minimal amount of extraneous fluid should be delivered. For example, thepledget 18, once inside the needle, may be delivered with about 0.02 to 1.5 ml of fluid depending on the size of theneedle 16 used. Injection of larger amounts of fluid may distend the biopsy tract or displace the pledget within the organ. - According to one example, a
pledget 18 having a size of approximately 20 mm by 2 mm cut from a sheet of commercially available Gelfoam having a thickness of approximately 1.5 mm can be hydrated and injected through a standard 18 gauge, approximately 15 cm long biopsy needle with approximately 0.9 ml of fluid. An adaptor according to this example has a first diameter D1 of about 0.38 cm, a second diameter D2 of about 0.14 cm, a total length of about 3.80 cm, and a taper angle of about 45°. About 0.3 ml of fluid is injected slowly to hydrate thepledget 18 and fill the adaptor with a column of fluid. Approximately 0.3 ml of fluid is then injected to load thepledget 18 from theadaptor 12 into thebiopsy needle 16. Finally, about 0.3 ml of fluid is injected to deliver thepledget 18 into the biopsy tract. Loading of the pledget from theadaptor 12 into theneedle 16 and delivery from the needle to the biopsy tract can be combined in one step by delivery of approximately 0.6 ml. Accurate and complete injection of the pledget with a minimum amount of extraneous fluid is achieved by this volumetric injection technique. - According to an alternative embodiment of the adaptor illustrated in FIG. 5, vent holes44 extend through the side walls of the
adapter 12 adjacent thesecond end 34 for venting fluid during loading of thepledget 18. As illustrated in FIG. 5, the user places a finger over thesecond end 34 of theadaptor 12 to prevent the pledget from exiting the adaptor. Theplunger 50 of thesyringe 14 is then depressed slowly causing fluid to pass into theadaptor 12 and hydrate the pledget. Preferably, the user waits a few seconds once the fluid is injected into theadaptor 12 until thepledget 18 is hydrated. Once thepledget 18 is hydrated, additional fluid is then injected quickly into theadaptor 12 to move thepledget 18 from thefirst end 30 of the adaptor towards thesecond end 34 of the adaptor. As thepledget 18 is compressed by the taperedsection 42 of the adaptor 12 air and fluid are allowed to escape from the adaptor through the vent holes 44. Once thepledget 18 has been moved into the position illustrated in FIG. 5 adjacent thesecond end 34, fluid injection is halted. Theadaptor 12 with thehydrated pledget 18 within the distal end is ready to insert the pledget through a biopsy needle to facilitate hemostasis within the biopsy tract. - As an alternative to placement of a finger at the distal end of the
adaptor 12 during advancement of thepledget 18 through the taperedsection 42, a removable cap may be used. Further, the vent holes 44 may be omitted and a screen or a cap having a screen may be used to allow fluid to pass through the screen while the screen prevents thepledget 18 from being ejected. One example of a vent cap will be described in further detail below with respect to FIGS. 14 and 15. - An alternative embodiment of the delivery system is illustrated in FIG. 7 in which an
adaptor 12 is provided with apressure indicator 64 to monitor pledget injection. Preferably, thepressure indicator 64 is removably attached at a luer fitting 66 provided on a side of theadaptor 12. Thepressure indicator 64 includes apressure dome 68 movable from the convex shaped extended position illustrated in FIG. 7 to a flat position depending on the pressure inside theadaptor 12. Internal pressure within thebiopsy needle 16, theadaptor 12, and thesyringe 14 will drop as thepledget 18 is extruded from the biopsy needle into the biopsy tract. This causes thepressure dome 68 to move from the convex position illustrated in FIG. 7 to a flat position, indicating that pledget delivery is complete. - FIG. 8 illustrates an alternative embodiment of an
adaptor 12 a in which the taperedsection 42 a is shorter and more abrupt. The particular size and shape of theadaptor 12 a according to either FIG. 2 or FIG. 8 may vary depending on the size of biopsy needle, the tissue sample size, and the size of piedget to be delivered. One example of theadaptor 12 a of FIG. 8 for delivery of anabsorbable sponge pledget 18 through an approximately 18 gauge biopsy needle has a first adaptor diameter D1 of about 0.25 cm or greater, preferably about 0.30 to 0.80 cm and a second adaptor diameter D2 of about 0.25 cm or less, preferably, about 0.05 to 0.23 cm. An angle made by a wall of the taperedsection 42 a with a longitudinal axis of theadaptor 12 a may vary from about 5° to 90°, but is preferably between about 30° and 60°. The taperedsection 42 a is illustrated with a substantially planar interior surface, when shown in cross section. However, the taperedsection 42 a may also have a convex or concave surface in cross section. The dimensions described for theadaptor 12 a are appropriate for use with an approximately 18 gauge biopsy needle commonly used for liver biopsies. For some of the much larger biopsy needles or cannulas used for skin or breast biopsies the adaptor dimensions would be scaled up accordingly. - FIG. 8 also shows a
connector 70 for connecting theadaptor 12 to asyringe 14 when the proximal end of the adaptor is larger in diameter than the standard syringe fitting. Theconnector 70 includes afirst end 72 for connection to thesyringe 14 and asecond end 74 for connection to theadaptor 12. - One type of absorbable sponge material which is acceptable for use in the present invention is Gelfoam, manufactured by the Upjohn Company. Gelfoam is a porous, pliable, cross-linked gelatin material and is available commercially in sheet form as pre-compressed or non-compressed sponge. The material may be provided preformed as a
pledget 18 or may be cut with apunch 10, or a stencil or template and knife to form a pledget as described above. Once hydrated, thepledget 18 can be easily compressed to fit into a lumen having a smaller cross sectional area than the original cross sectional area of the pledget. Additionally, the kneading of thehydrated pledget 18 during delivery encourages air trapped within the Gelfoam to be expelled and replaced with fluid, allowing rapid expansion upon delivery. When apledget 18 of a pre-compressed Gelfoam is hydrated and kneaded (expelling air) during delivery, the pledget will have the absorbtion capacity to rapidly expand to many times (e.g., 3 or more times) its original dry volume upon delivery. When apledget 18 of the non-compressed Gelfoam is hydrated and kneaded (expelling air) during delivery, the pledget will have the absorbtion capacity to rapidly expand to its original dry volume upon delivery. These properties make the Gelfoam sponge material particularly useful for facilitating hemostasis of biopsy sites. - Abrupt lumen diameter changes within or between the
adaptor 12 or theneedle 16 will improve “kneading” of the absorbable sponge material improving hydration of the absorbable sponge material thereby improving the expansion properties of the hydrated delivered absorbable sponge. According to the alternative embodiments of the adaptor illustrated in FIGS. 9 and 10, enlarged, recessed, or irregular areas in the lumen of the adaptor are provided to impart additional kneading action to the absorbable sponge material further improving expansion properties of the sponge. - The
adaptor 12 b of FIG. 9 includes twoenlarged areas 72 of the lumen. As theabsorbable sponge pledget 18 passes through the lumen of theadaptor 12 b the material expands and is compressed by the adaptor to increase kneading of the pledget. FIG. 10 illustrates another alternative embodiment of theadaptor 12 c including a lumen with a plurality ofstaggered irregularities 74 for improved kneading of theabsorbable sponge pledget 18. Theirregularities 74 will preferably have a relatively smooth surface to prevent the absorbable sponge material from becoming caught on the irregularities. - FIG. 11 illustrates an alternative embodiment of an
adaptor 112 with apledget formation template 122 attached to the adaptor. As shown in FIG. 11, theadaptor 112 includes aproximal end 130 having afemale luer 132 and adistal end 134 having amale luer 136. Thepledget 118 is inserted in theproximal end 130. Atapered section 142 is provided within theadaptor 112 for compressing thepledget 118 into the biopsy needle. - When delivering a
pledget 118 of absorbable sponge material, it is important to deliver a desired amount of the sponge material using a minimum amount of fluid. Some devices and methods which allow the delivery of sponge material with a minimum amount of fluid include the use of the pledget configuration illustrated in FIG. 11, the use of a vent cap for staging of the pledget as illustrated in FIGS. 14 and 15, and the withdrawal of the biopsy needle during delivery as illustrated in FIG. 16. - Pledgets118 having increased proximal cross sectional areas are more easily delivered than pledgets with constant cross sectional areas or decreased proximal cross sectional areas. FIG. 11 illustrates a
pledget 118 having a proximal cross sectional area which is approximately twice its distal cross sectional area. The smaller material mass at the distal end of the pledget 188 increases the ease of inserting the pledget into theadaptor 112. The smaller distal end of the pledget also passes through the delivery cannula or biopsy needle without creating a large back pressure to resist the delivery of the pledget through the cannula. The larger proximal section of thepledget 118 provides a better seal within the interior of theadaptor 112 and thecannula 16 which allows a minimum amount of fluid to be used to advance the pledget. The increased material at the proximal end of thepledget 118 also increases the amount of sponge material delivered to the biopsy tract. - Pledgets118 with increased cross sectional area proximal ends may be prepared in a variety of manners. For example, if a
pledget 118 is prepared from a sheet of sponge material, the increased proximal mass can be achieved by cutting the pledget with an enlarged proximal end. Alternatively, thepledget 118 may be formed by folding, rolling, compressing, or otherwise manipulating the sponge material to the desired shape. The proximal pledget mass may also be increased by adding separate pieces of material to the proximal end of the pledget. This additional material may be layered, wrapped, coiled or attached to the pledget in any other manner. The pledgets may also be formed by molding, bump extruding, dipping, or the like. The larger cross sectional area proximal end is generally about 1.2 to 4 times the cross sectional area of the distal end. In addition, the proximal end with the larger cross section area preferably extends along about ⅛ to ¾ of the total pledget length. - The
pledget 118 illustrated in FIG. 11 has been formed by cutting a strip of material from anabsorbable sponge sheet 20 with the aid of thetemplate 122 as illustrated in FIG. 13. After the strip is cut, the proximal end of the strip is then folded back onto itself to form apledget 118 with an increased cross sectional area and material mass at a proximal end. One example of a preferred embodiment of a Gelfoam pledget for delivery down a 20 gauge biopsy needle or cannula has a size of approximately 0.1×1.5×0.06 inches and is folded as illustrated in FIG. 11 to an overall length of about 0.9 inches. Placing thispledget 118 in anadaptor 112 having a largest internal diameter of 0.125 inches allows the pledget to be delivered to a 20 gauge or larger biopsy needle. Other common biopsy procedures use an 18 gauge or larger biopsy needle through a slightly larger guide cannula and would receive a somewhat larger pledget. After taking a core sample and removing the biopsy needle from the cannula guide, apledget 118 maybe delivered through the cannula to the biopsy site. Thepledget 118 for use in the system employing an 18 gauge or larger biopsy needle may be formed from a strip which is approximately 0.11-0.12 inches wide by about 3.125 inches long with a thickness of about 0.06 inches and folded to an overall length of about 2.2 inches. This pledget having a single thickness distal end and double thickness proximal end can be delivered from an adaptor having a largest internal diameter of approximately 0.125 inches. - One method for forming the
pledget 118 with the enlarged proximal end with the aid of atemplate 122 is illustrated in FIG. 13. Thetemplate 122 is a flatplate having recesses 124 along one or more edges of the template. Therecesses 124 have a width and a length which corresponds to a preferred width and length of the pledget. Therecesses 124 form a raisedbar 126 at a location where the pledget should be folded. When the template is pressed onto asheet 20 of absorbable sponge material, thebar 126 makes an indentation or groove in the sponge material. A user cuts along theside 128 and end 129 edges of thetemplate 122 with a blade to form a strip of the sponge material which is then folded along the groove or crease formed by thebar 126 to form thepledget 118. It is important to securely hold the sponge sheet by applying downward pressure to thetemplate 122 during cutting to prevent tearing and breaking of the sponge material. Prior to folding the strip of sponge material to form the pledget, the strip may be compressed with a flat surface of the template to compact the sponge and assist in loading the pledget into theadaptor 112. - Although the
template 122 has been illustrated as a plate which is attached to theadaptor 112, it should be understood that the template can also be a separate member. In addition, thetemplate 122 may provide guides for forming pledgets of different sizes for delivery through different sized biopsy needles. Thetemplate 122 may be provided with or without the creasingbar 126 and may be transparent or opaque. In the opaque version, the edges of therecesses 124 are used to align the template with an edge of thesponge sheet 20. In contrast, in a transparent version of the template, therecesses 124 may be eliminated and a visual indication or line may be provided which assists in aligning an edge of the sponge sheet with the template. - FIGS. 14 and 15 illustrate a
preferred vent cap 70 for use with theadapter 112. As discussed above with respect to FIG. 5, vents maybe used to assist in hydrating and staging the pledget within the adapter. In particular, vents will allow the pledget to be moved to a preferred axial location within theadapter 112 prior to delivery. In addition, the vents allow fluid to be injected and air to be removed from the pledget prior to delivery. Thevent cap 70 as illustrated in FIG. 14 includes afemale luer connector 72 including aflange 74 which is received on themale luer 136 of theadapter 112. Thevent cap 70 also includes aconical portion 76 which is configured to extend into adistal end 134 of theadaptor 112. Theconical portion 76 has one or more fluid paths or ventholes 78 which allow air and fluid to exit through the vent cap but prevent the absorbable sponge material of thepledget 118 from passing through the vent cap. The vent hole may alternatively be positioned between thevent cap 70 and theadapter 112. Preferably, an exterior of theconical portion 76 forms a seal with the lumen of theadaptor 112 at the distal end. The diameter of thevent hole 78 is approximately 0.005-0.02 inches, preferably approximately 0.01 inches. Thissmall vent hole 78 allows the purging and venting of fluid and air from theadapter 112 but does not allow thepledget 118 to pass through the venthole, even at high pressures such as 5 psi or greater. The use of thevent cap 70 allows the user to apply high pressures with the syringe used to hydrate the pledget. The high pressures drive the fluid into the pledget causing rapid and thorough hydration of the sponge material. Repeated pulsing of the fluid with the syringe will provide more complete hydration of the pledget. - The
vent cap 70 also positions thepledget 118 at a preferred axial position just proximal to thedistal end 134 of theadapter 112 as illustrated in FIG. 15. This positioning of thepledget 118 away from the end of the adaptor prevents the pledget from becoming trapped between theadaptor 112 and thebiopsy needle hub 28 which is attached to the distal end of the adaptor. In addition, after hydration of the pledget and removal of thevent cap 70 the sponge material may tend to swell out of the distal end of theadapter 112. Accordingly, theconical portion 76 of thevent cap 70 preferably extends into theadaptor 112 approximately 0.01 to 0.1 inches, more preferably about 0.01 to 0.03 inches. - According to the present invention, the portion of the
vent cap 70 which extends into the lumen of theadaptor 112 can be any desired shape such as dome-shaped, cylindrical, conical or other shape. - As described above, the pledget maybe delivered to the biopsy tract by holding the biopsy needle or
cannula 16 stationary and injecting the pledget through the biopsy needle. If additional pledgets are to be delivered, thebiopsy needle 16 is withdrawn a distance sufficient to accommodate an additional pledget and the additional pledget is then injected. - According to an alternative embodiment of the invention, the method of delivering the pledget into the biopsy tract may include withdrawing the biopsy needle or
cannula 16 during delivery of thepledget 18 to deliver the pledget in an elongated trail which follows the biopsy tract. Placing the absorbable sponge material in a trail which fills the entire biopsy tract provides the added benefit of providing hemostasis along the entire biopsy tract. This is particularly helpful for stopping the bleeding of biopsy tracts in organs which tend to have excessive bleeding such as the liver, kidney, spleen, and other vascular organs. - In order to achieve a trail of absorbable sponge material in the biopsy tract, one method of the present invention involves the delivery of the pledget into the biopsy needle by a predetermined amount of fluid. The biopsy needle is then withdrawn at a velocity V while the pledget material is ejected from the biopsy needle at a velocity E with respect to the biopsy needle. The velocity V at which the biopsy needle is withdrawn is equal to or less than the velocity E at which the absorbable sponge material is delivered. The control of injection of fluid and withdrawal of the needle to achieve the desired trail of absorbable sponge material in the biopsy tract maybe controlled with an injection controlling device.
- According to an alternative embodiment of the invention illustrated in FIG. 16, the adaptor maybe used to deliver the pledget into the
biopsy needle 16 and then the adaptor is removed from the biopsy needle. A plunger orstylet 80 which is generally provided with thebiopsy needle 16 for inserting the biopsy needle is then used to deliver the pledget from the biopsy needle. As shown in FIG. 16, the biopsy needle extends through thetissue 84 and into theorgan 86 for removal of a core of tissue. After biopsy, the pledget is injected into theneedle 16 and theplunger 80 is placed within the biopsy needle so that a distal end of the plunger abuts the proximal end of thepledget 118. Theplunger 80 is then held stationary while thebiopsy needle 16 is withdrawn from the biopsy site. Theplunger 80 causes thepledget 118 to be delivered in atrail 88 which fills the biopsy tract. Thetrail 88 preferably extends along the entire biopsy tract to or past a surface of theorgan 86. The delivery of thetrail 88 of absorbable sponge material provides an advantage over the delivery of discrete blobs of material because the trail is able to provide hemostasis along the entire tract. In contrast, if a blob of absorbable sponge material is delivered within the tract at a depth of 1-2 cm from the surface of the organs, this 1-2 cm of biopsy tract may continue to bleed significantly. - As an alternative to delivery of the pledget as a trail, the pledget may be delivered as a plug. To deliver a plug the
plunger 80 is advanced into theneedle 16 pushing the pledget out of the distal end of the needle while the needle is held stationary. A combination of delivery of plugs and trails may also be used. The pledget material may be delivered entirely within a single anatomical structure or may cross two or more anatomical structures such as an organ, surrounding tissue and facial layer. - Although the invention is primarily intended for delivery of absorbable sponge, non-absorbable sponge may also be delivered with the devices, systems, and methods of the present invention. A non-absorbable sponge may be desirable where it will be necessary to locate the biopsy site or tract after the procedure.
- Although the
pledget 18 has been shown and described as having a rectangular cross section, pledgets of other shapes may also be used. For example, the pledget may be preformed in any shape, such as with a rectangular or circular cross section or may be rolled from a thin sheet of absorbable sponge material. Thepledget 18 may have a multi-sided cross section, a star shaped cross section, or a folded cross section and may have through or blind holes formed in the dry pledget. In addition, the pledget size and shape can be matched to the size and shape of a particular delivery site. Pledget shapes having greater surface area provided by features such as fins provide faster hydration. - The continuous structure of the
absorbable sponge pledget 18 provides more secure and reliable placement than a paste or liquid and can even facilitate partial withdrawal, removal, or movement of the delivered pledget. - In some instances it may be desirable to deliver multiple pledgets in spaced apart positions along the biopsy tract, particularly for a long biopsy tract. For delivery of additional pledgets, the
biopsy needle 16 is retracted a distance sufficient to provide a space to accommodate anadditional pledget 18 and the injection procedure described above is repeated for the additional pledget(s). For a particularly large biopsy site or cavity,additional pledgets 18 may be injected beside an initially injected pledget until the cavity is filled. - Although biopsy is most commonly performed by biopsy needle, biopsy may also be performed through other cannulas, such as catheters, long needles, endoscopes, or the like. The treatment procedure according to the present invention can be used for facilitating hemostasis of puncture wounds through different types of cannulas including needles, catheters, endoscopes, and the like. In addition, the treatment procedure and systems according to the present invention may be used to deliver absorbable or non-absorbable sponge for other therapys. For example, sponge may be delivered for cosmetic or reconstructive bulking or for temporary or permanent intravascular embolization.
- The
absorbable sponge pledget 18 may be used to deliver a beneficial agent, such as contrast agent, thrombin, radiation treatment, or the like. The pledget can also be used to deliver therapeutic agents, such as radioactive isotopes for localized treatment of tumors, anti-cancer agents, anti-metastatic agents, and the like. Examples of anticancer agents include 5-fluorouracil, cisplatin, prednisone, and others described in U.S. Pat. No. 4,619,913 which is incorporated herein by reference. Theabsorbable sponge pledget 18 may be presoaked with the beneficial agent for delivery to the biopsy tract. Alternatively, thepledget 18 may be hydrated with the beneficial liquid agent or the agent may be delivered to the pledget after the pledget is placed within the biopsy tract. - A pledget formed of commercially available Gelfoam material will be absorbed by the body within 1 to 6 weeks. However, the pledget material may be designed to provide different rates of absorption. For example, Gelfoam can be designed to be absorbed at different rates by varying the degree of cross-linking. Preferably, the pledget is designed to be absorbed in less than one month.
- The treatment of a biopsy tract with a hydrated and injected
pledget 18 of absorbable sponge to facilitate hemostasis provides substantial advantages in comfort over external pressure methods. In addition, the present invention also provides advantages over the insertion of an absorbable sponge material in a dry state with an applicator. In particular, theadaptor 12 allows a relatively large pledget to be compressed and inserted into the biopsy tract in a hydrated state. The injectedpledget 18 conforms in shape quickly to the shape of the biopsy tract and immediately begins blocking blood flow. In contrast, a dry piece of sponge material must be cut to the particular size of the biopsy tract and does not swell to fill the tract until the blood has sufficiently saturated the sponge material which can take significantly longer and provides inadequate local compression. - While the invention has been described in detail with reference to the preferred embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made and equivalents employed, without departing from the present invention.
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/953,395 US6440153B2 (en) | 1998-05-01 | 2001-09-14 | Device and method for facilitating hemostasis of a biopsy tract |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/071,670 US6071301A (en) | 1998-05-01 | 1998-05-01 | Device and method for facilitating hemostasis of a biopsy tract |
US09/247,880 US6086607A (en) | 1998-05-01 | 1999-02-10 | Device and method for facilitating hemostasis of a biopsy tract |
US61305900A | 2000-07-10 | 2000-07-10 | |
US09/953,395 US6440153B2 (en) | 1998-05-01 | 2001-09-14 | Device and method for facilitating hemostasis of a biopsy tract |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US61305900A Continuation | 1998-05-01 | 2000-07-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020016611A1 true US20020016611A1 (en) | 2002-02-07 |
US6440153B2 US6440153B2 (en) | 2002-08-27 |
Family
ID=22102830
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/071,670 Expired - Lifetime US6071301A (en) | 1995-09-15 | 1998-05-01 | Device and method for facilitating hemostasis of a biopsy tract |
US09/247,880 Expired - Lifetime US6086607A (en) | 1998-05-01 | 1999-02-10 | Device and method for facilitating hemostasis of a biopsy tract |
US09/589,036 Expired - Lifetime US6440151B1 (en) | 1998-05-01 | 2000-06-06 | Device and method for facilitating hemostasis of a biopsy tract |
US09/953,395 Expired - Lifetime US6440153B2 (en) | 1998-05-01 | 2001-09-14 | Device and method for facilitating hemostasis of a biopsy tract |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/071,670 Expired - Lifetime US6071301A (en) | 1995-09-15 | 1998-05-01 | Device and method for facilitating hemostasis of a biopsy tract |
US09/247,880 Expired - Lifetime US6086607A (en) | 1998-05-01 | 1999-02-10 | Device and method for facilitating hemostasis of a biopsy tract |
US09/589,036 Expired - Lifetime US6440151B1 (en) | 1998-05-01 | 2000-06-06 | Device and method for facilitating hemostasis of a biopsy tract |
Country Status (8)
Country | Link |
---|---|
US (4) | US6071301A (en) |
EP (1) | EP1075219B8 (en) |
JP (1) | JP4139562B2 (en) |
AU (1) | AU751444B2 (en) |
CA (1) | CA2330590A1 (en) |
DE (1) | DE69932612T2 (en) |
ES (1) | ES2270594T3 (en) |
WO (1) | WO1999056632A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050216018A1 (en) * | 2004-03-29 | 2005-09-29 | Sennett Andrew R | Orthopedic surgery access devices |
US20070074980A1 (en) * | 2005-09-02 | 2007-04-05 | Bankoski Brian R | Implant rehydration packages and methods of use |
US20080027389A1 (en) * | 2003-02-12 | 2008-01-31 | Katsuhiro Hiejima | Indwelling catheter |
US20080187524A1 (en) * | 2003-04-25 | 2008-08-07 | Medtronic Vascular, Inc. | Cellular Therapy to Heal Vascular Tissue |
US20080208320A1 (en) * | 2006-12-15 | 2008-08-28 | Francisca Tan-Malecki | Delivery Apparatus and Methods for Vertebrostenting |
US20090326538A1 (en) * | 2006-12-15 | 2009-12-31 | Sennett Andrew R | Devices and methods for fracture reduction |
EP2465450A1 (en) * | 2010-12-20 | 2012-06-20 | Tyco Healthcare Group LP | Self Deploying Bodily Opening Protector |
US9480485B2 (en) | 2006-12-15 | 2016-11-01 | Globus Medical, Inc. | Devices and methods for vertebrostenting |
US11865276B2 (en) | 2012-06-15 | 2024-01-09 | W. L. Gore & Associates, Inc. | Vascular occlusion and drug delivery devices, systems, and methods |
Families Citing this family (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10508504A (en) * | 1994-09-16 | 1998-08-25 | バイオプシス メディカル インコーポレイテッド | Method and apparatus for identifying and marking tissue |
US6071300A (en) * | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6183497B1 (en) * | 1998-05-01 | 2001-02-06 | Sub-Q, Inc. | Absorbable sponge with contrasting agent |
US6071301A (en) | 1998-05-01 | 2000-06-06 | Sub Q., Inc. | Device and method for facilitating hemostasis of a biopsy tract |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US6270464B1 (en) * | 1998-06-22 | 2001-08-07 | Artemis Medical, Inc. | Biopsy localization method and device |
US6347241B2 (en) * | 1999-02-02 | 2002-02-12 | Senorx, Inc. | Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it |
US6161034A (en) * | 1999-02-02 | 2000-12-12 | Senorx, Inc. | Methods and chemical preparations for time-limited marking of biopsy sites |
US6315753B1 (en) | 1998-05-01 | 2001-11-13 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US6200328B1 (en) | 1998-05-01 | 2001-03-13 | Sub Q, Incorporated | Device and method for facilitating hemostasis of a biopsy tract |
US6610026B2 (en) | 1998-05-01 | 2003-08-26 | Sub-Q, Inc. | Method of hydrating a sponge material for delivery to a body |
US20010045575A1 (en) * | 1998-05-01 | 2001-11-29 | Mark Ashby | Device and method for facilitating hemostasis of a biopsy tract |
US20020058882A1 (en) * | 1998-06-22 | 2002-05-16 | Artemis Medical, Incorporated | Biopsy localization method and device |
US6036698A (en) | 1998-10-30 | 2000-03-14 | Vivant Medical, Inc. | Expandable ring percutaneous tissue removal device |
US9669113B1 (en) | 1998-12-24 | 2017-06-06 | Devicor Medical Products, Inc. | Device and method for safe location and marking of a biopsy cavity |
US6371904B1 (en) | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US20080039819A1 (en) * | 2006-08-04 | 2008-02-14 | Senorx, Inc. | Marker formed of starch or other suitable polysaccharide |
US7983734B2 (en) * | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US20090216118A1 (en) * | 2007-07-26 | 2009-08-27 | Senorx, Inc. | Polysaccharide markers |
US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
US7651505B2 (en) | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
WO2000047115A1 (en) * | 1999-02-10 | 2000-08-17 | Sub-Q, Inc. | Device and method for facilitating hemostasis of a biopsy tract |
US6554851B1 (en) * | 1999-05-07 | 2003-04-29 | Scimed Life Systems, Inc. | Methods of sealing an injection site |
US6575991B1 (en) | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
US6515273B2 (en) * | 1999-08-26 | 2003-02-04 | Masimo Corporation | System for indicating the expiration of the useful operating life of a pulse oximetry sensor |
US6984219B2 (en) * | 1999-09-23 | 2006-01-10 | Mark Ashby | Depth and puncture control for blood vessel hemostasis system |
US7695492B1 (en) | 1999-09-23 | 2010-04-13 | Boston Scientific Scimed, Inc. | Enhanced bleed back system |
WO2001083174A1 (en) * | 2000-04-28 | 2001-11-08 | Sub-Q, Inc. | Easy cutter |
US6540735B1 (en) | 2000-05-12 | 2003-04-01 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
WO2002005865A2 (en) * | 2000-07-14 | 2002-01-24 | Sub-Q, Inc. | Sheath-mounted arterial plug delivery device |
AU2002245125A1 (en) * | 2000-11-06 | 2002-07-08 | Francis C. Classe | Biopsy and coagulant device |
WO2002041786A2 (en) | 2000-11-20 | 2002-05-30 | Senorx, Inc. | Tissue site markers for in vivo imaging |
US6840952B2 (en) * | 2000-12-07 | 2005-01-11 | Mark B. Saker | Tissue tract sealing device |
EP1406671A1 (en) * | 2001-03-12 | 2004-04-14 | Sub Q, Inc. | Methods for sterilizing cross-linked gelatin compositions |
US8187625B2 (en) | 2001-03-12 | 2012-05-29 | Boston Scientific Scimed, Inc. | Cross-linked gelatin composition comprising a wetting agent |
JP4267867B2 (en) * | 2001-05-03 | 2009-05-27 | ラディ・メディカル・システムズ・アクチェボラーグ | Wound occlusion element guide device |
US6511457B2 (en) * | 2001-05-04 | 2003-01-28 | Garey Thompson | Airless syringe |
US6863680B2 (en) * | 2001-11-08 | 2005-03-08 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US7008440B2 (en) * | 2001-11-08 | 2006-03-07 | Sub-Q, Inc. | System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
AU2002320182B2 (en) * | 2001-06-29 | 2008-02-21 | Cook Biotech Incorporated | Porous sponge matrix medical devices and methods |
US6592608B2 (en) * | 2001-12-07 | 2003-07-15 | Biopsy Sciences, Llc | Bioabsorbable sealant |
US7037323B2 (en) * | 2001-11-08 | 2006-05-02 | Sub-Q, Inc. | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US7192436B2 (en) * | 2001-11-08 | 2007-03-20 | Sub-Q, Inc. | Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure |
US20040102730A1 (en) * | 2002-10-22 | 2004-05-27 | Davis Thomas P. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US7455680B1 (en) | 2002-11-04 | 2008-11-25 | Boston Scientific Scimed, Inc. | Apparatus and method for inhibiting blood loss |
US7955353B1 (en) | 2002-11-04 | 2011-06-07 | Sub-Q, Inc. | Dissolvable closure device |
US8317821B1 (en) | 2002-11-04 | 2012-11-27 | Boston Scientific Scimed, Inc. | Release mechanism |
US20060036158A1 (en) | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US20040122349A1 (en) * | 2002-12-20 | 2004-06-24 | Lafontaine Daniel M. | Closure device with textured surface |
US8709038B2 (en) * | 2002-12-20 | 2014-04-29 | Boston Scientific Scimed, Inc. | Puncture hole sealing device |
US6790185B1 (en) * | 2002-12-31 | 2004-09-14 | Biopsy Sciences, Llc | Sealant plug delivery methods |
US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
US20050119562A1 (en) * | 2003-05-23 | 2005-06-02 | Senorx, Inc. | Fibrous marker formed of synthetic polymer strands |
US7169114B2 (en) * | 2003-06-04 | 2007-01-30 | Krause William R | Biopsy and delivery device |
US7942897B2 (en) * | 2003-07-10 | 2011-05-17 | Boston Scientific Scimed, Inc. | System for closing an opening in a body cavity |
US7744852B2 (en) | 2003-07-25 | 2010-06-29 | Rubicor Medical, Llc | Methods and systems for marking post biopsy cavity sites |
US7537788B2 (en) | 2003-07-25 | 2009-05-26 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20050020899A1 (en) * | 2003-07-25 | 2005-01-27 | Rubicor Medical, Inc. | Post-biopsy cavity treatmetn implants and methods |
US7931670B2 (en) * | 2003-10-15 | 2011-04-26 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with automatic tamping |
US8337522B2 (en) * | 2003-10-15 | 2012-12-25 | St. Jude Medical Puerto Rico Llc | Vascular sealing device with locking hub |
US20050090860A1 (en) * | 2003-10-23 | 2005-04-28 | Paprocki Loran J. | Segmented plug for tissue tracts |
US20050273002A1 (en) | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
US7875043B1 (en) | 2003-12-09 | 2011-01-25 | Sub-Q, Inc. | Cinching loop |
US8062230B1 (en) | 2004-10-14 | 2011-11-22 | Suros Surgical Systems, Inc. | Surgical site marker delivery system |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
US7749247B2 (en) * | 2005-08-04 | 2010-07-06 | St. Jude Medical Puerto Rico, Llc | Tissue puncture closure device with coiled automatic tamping system |
CA2562580C (en) | 2005-10-07 | 2014-04-29 | Inrad, Inc. | Drug-eluting tissue marker |
US8349443B2 (en) * | 2006-02-23 | 2013-01-08 | Meadwestvaco Corporation | Method for treating a substrate |
US20070213670A1 (en) * | 2006-03-09 | 2007-09-13 | Gabel Jonathan B | Endoscopic applicator |
US20070244377A1 (en) * | 2006-03-14 | 2007-10-18 | Cozad Jenny L | Pulse oximeter sleeve |
ES2443526T3 (en) | 2006-10-23 | 2014-02-19 | C.R. Bard, Inc. | Breast marker |
US20080105580A1 (en) * | 2006-11-02 | 2008-05-08 | Tyco Healthcare Group Lp | Applicator Tip |
FR2908284B1 (en) * | 2006-11-14 | 2009-11-27 | Protomed | OCCLUSION PLUG DELIVERY DEVICE. |
US9579077B2 (en) | 2006-12-12 | 2017-02-28 | C.R. Bard, Inc. | Multiple imaging mode tissue marker |
EP2101670B1 (en) | 2006-12-18 | 2013-07-31 | C.R.Bard, Inc. | Biopsy marker with in situ-generated imaging properties |
US7993367B2 (en) * | 2007-09-28 | 2011-08-09 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
WO2009099767A2 (en) | 2008-01-31 | 2009-08-13 | C.R. Bard, Inc. | Biopsy tissue marker |
US8029533B2 (en) | 2008-04-04 | 2011-10-04 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US9364206B2 (en) * | 2008-04-04 | 2016-06-14 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
DE102008061535A1 (en) * | 2008-12-03 | 2010-06-10 | Aesculap Ag | Medical absorbent body, in particular for the removal of wound fluids from human and / or animal body cavities, and method for its production |
DE102008061536A1 (en) * | 2008-12-03 | 2010-06-10 | Aesculap Ag | Medical-technical absorbent body, in particular for the removal of wound fluids from human and / or animal body cavities |
US20100160777A1 (en) * | 2008-12-22 | 2010-06-24 | Hardin Terry D | Reverse deployment device |
WO2010077244A1 (en) | 2008-12-30 | 2010-07-08 | C.R. Bard Inc. | Marker delivery device for tissue marker placement |
US8226575B2 (en) * | 2009-05-15 | 2012-07-24 | Mayo Foundation For Medical Education And Research | Biopsy needle assemblies |
US9014787B2 (en) | 2009-06-01 | 2015-04-21 | Focal Therapeutics, Inc. | Bioabsorbable target for diagnostic or therapeutic procedure |
WO2011005482A2 (en) * | 2009-06-22 | 2011-01-13 | University Of Washington | Controllable transverse rotation adaptor |
WO2011057131A1 (en) | 2009-11-09 | 2011-05-12 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
JP2013509963A (en) | 2009-11-09 | 2013-03-21 | スポットライト テクノロジー パートナーズ エルエルシー | Fragmented hydrogel |
US9370626B2 (en) | 2009-11-24 | 2016-06-21 | University Of Florida Research Foundation, Inc. | Apparatus and methods for blocking needle and cannula tracts |
US9277904B2 (en) | 2010-05-19 | 2016-03-08 | Cook Medical Technologies Llc | Devices and methods useful for sealing bodily openings |
US8932325B2 (en) | 2010-05-19 | 2015-01-13 | Cook Medical Technologies Llc | Devices and methods useful for sealing bodily openings |
US8685059B2 (en) | 2010-06-08 | 2014-04-01 | Essential Medical Llc | Self-locking closure device for percutaneously sealing punctures |
DE102011002193B4 (en) * | 2011-04-20 | 2018-11-29 | Leica Biosystems Nussloch Gmbh | Tissue specimen handling device |
US10485524B2 (en) | 2011-10-25 | 2019-11-26 | Essential Medical, Inc. | Instrument and methods for surgically closing percutaneous punctures |
US9642604B2 (en) * | 2012-04-12 | 2017-05-09 | Phillips Medical Llc | Hemostatic system and its methods of use |
US20130289389A1 (en) | 2012-04-26 | 2013-10-31 | Focal Therapeutics | Surgical implant for marking soft tissue |
US9757104B2 (en) | 2012-07-19 | 2017-09-12 | Essential Medical, Inc. | Multi-lumen tamper tube |
US9943298B2 (en) | 2012-10-19 | 2018-04-17 | Cook Medical Technologies Llc | Vascular closure with shape memory characteristic |
US10070850B2 (en) | 2012-10-19 | 2018-09-11 | Cook Medical Technologies Llc | Vascular closure with multiple connections |
US20140172012A1 (en) | 2012-12-13 | 2014-06-19 | Cook Medical Technologies Llc | Vascular closure device suture tension mechanism |
US10758216B2 (en) | 2013-03-14 | 2020-09-01 | Cook Medical Technologies Llc | Internal closure systems and devices |
US9724082B2 (en) | 2013-03-15 | 2017-08-08 | Cook Medical Technologies Llc | Delivery system for tissue opening closures |
US10639019B2 (en) | 2013-03-15 | 2020-05-05 | Arrow International, Inc. | Vascular closure devices and methods of use |
US10154835B2 (en) | 2013-05-09 | 2018-12-18 | Essential Medical, Inc. | Vascular closure device with conforming plug member |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
EP3858254A1 (en) | 2013-12-23 | 2021-08-04 | Arrow International LLC | Vascular closure device |
EP3171820B1 (en) | 2014-07-25 | 2022-11-16 | Hologic, Inc. | Implantable devices and techniques for oncoplastic surgery |
US10555727B2 (en) | 2015-06-26 | 2020-02-11 | Essential Medical, Inc. | Vascular closure device with removable guide member |
JP7269460B2 (en) * | 2016-04-01 | 2023-05-09 | メリット・メディカル・システムズ・インコーポレイテッド | Medical device for delivering plugs to voids |
WO2017176787A1 (en) | 2016-04-04 | 2017-10-12 | Merit Medical Systems, Inc. | Medical plug delivery devices with a rotatable magazine and related components and methods |
CA3036580A1 (en) | 2016-09-12 | 2018-03-15 | Westrock Packaging Systems, Llc | Applicator plate, apparatus and method |
CN107252335B (en) * | 2017-06-28 | 2023-02-28 | 王洛 | Hemostasis device and injector for pushing hemostasis device |
US11219502B2 (en) | 2017-09-11 | 2022-01-11 | Medtronic Advanced Energy, Llc | Transformative shape-memory polymer tissue cavity marker devices, systems and deployment methods |
US11324567B2 (en) | 2018-02-01 | 2022-05-10 | Medtronic Advanced Energy, Llc | Expandable tissue cavity marker devices, systems and deployment methods |
AU2020266486A1 (en) | 2019-05-01 | 2021-12-02 | Westrock Packaging Systems, Llc | Article top engaging device, article carrier and blank therfor |
CN110051878A (en) * | 2019-05-28 | 2019-07-26 | 南昌大学第二附属医院 | The preparation method of Pen Zhu Shi Ming gelatin sponge gruel applied to central nervous system surgical hemostasis |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2899362A (en) * | 1959-08-11 | Hemostatic sponges and method of | ||
US581235A (en) * | 1897-04-20 | Island | ||
US1578517A (en) * | 1924-12-23 | 1926-03-30 | George N Hein | Valve piston and barrel construction for hypodermic syringes |
US2086580A (en) * | 1935-06-24 | 1937-07-13 | Myron C Shirley | Applicator |
US2465357A (en) * | 1944-08-14 | 1949-03-29 | Upjohn Co | Therapeutic sponge and method of making |
US2492458A (en) * | 1944-12-08 | 1949-12-27 | Jr Edgar A Bering | Fibrin foam |
US2507244A (en) * | 1947-04-14 | 1950-05-09 | Upjohn Co | Surgical gelatin dusting powder and process for preparing same |
CH264752A (en) * | 1947-06-03 | 1949-10-31 | Hoffmann La Roche | Process for the manufacture of carriers for pharmaceuticals. |
US2597011A (en) * | 1950-07-28 | 1952-05-20 | Us Agriculture | Preparation of starch sponge |
US2680442A (en) * | 1952-04-04 | 1954-06-08 | Frank L Linzmayer | Disposable suppository casing |
US2814294A (en) * | 1953-04-17 | 1957-11-26 | Becton Dickinson Co | Unit for and method of inhibiting and controlling bleeding tendencies |
US2824092A (en) * | 1955-01-04 | 1958-02-18 | Robert E Thompson | Process of preparation of a gelatincarboxymethyl cellulose complex |
US2761446A (en) * | 1955-03-30 | 1956-09-04 | Chemical Specialties Co Inc | Implanter and cartridge |
US3157524A (en) * | 1960-10-25 | 1964-11-17 | Ethicon Inc | Preparation of collagen sponge |
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4000741A (en) * | 1975-11-03 | 1977-01-04 | The Kendall Company | Syringe assembly |
SE7608618L (en) * | 1976-07-30 | 1978-02-01 | Medline Ab | CLOSURE OF CHANNELS |
US4588395A (en) * | 1978-03-10 | 1986-05-13 | Lemelson Jerome H | Catheter and method |
US4900303A (en) * | 1978-03-10 | 1990-02-13 | Lemelson Jerome H | Dispensing catheter and method |
US4323072A (en) * | 1980-01-18 | 1982-04-06 | Shiley, Incorporated | Cannula for a vein distention system |
US4340066A (en) * | 1980-02-01 | 1982-07-20 | Sherwood Medical Industries Inc. | Medical device for collecting a body sample |
US4390018A (en) * | 1980-09-15 | 1983-06-28 | Zukowski Henry J | Method for preventing loss of spinal fluid after spinal tap |
NZ205033A (en) * | 1982-08-12 | 1986-07-11 | Univ Alabama | Dispensing syringe with longitudinal slits in barrel |
US4515637A (en) * | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
US4619913A (en) * | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
US4619261A (en) * | 1984-08-09 | 1986-10-28 | Frederico Guerriero | Hydrostatic pressure device for bleeding control through an inflatable, stitchable and retrievable balloon-net system |
US4587969A (en) * | 1985-01-28 | 1986-05-13 | Rolando Gillis | Support assembly for a blood vessel or like organ |
US4708718A (en) | 1985-07-02 | 1987-11-24 | Target Therapeutics | Hyperthermic treatment of tumors |
US4890612A (en) * | 1987-02-17 | 1990-01-02 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4852568A (en) * | 1987-02-17 | 1989-08-01 | Kensey Nash Corporation | Method and apparatus for sealing an opening in tissue of a living being |
EP0292936B1 (en) * | 1987-05-26 | 1996-03-06 | Sumitomo Pharmaceuticals Company, Limited | Device for administering solid preparations |
US4829994A (en) * | 1987-05-27 | 1989-05-16 | Kurth Paul A | Femoral compression device for post-catheterization hemostasis |
US4850960A (en) * | 1987-07-08 | 1989-07-25 | Joseph Grayzel | Diagonally tapered, bevelled tip introducing catheter and sheath and method for insertion |
US4790819A (en) * | 1987-08-24 | 1988-12-13 | American Cyanamid Company | Fibrin clot delivery device and method |
US5195988A (en) * | 1988-05-26 | 1993-03-23 | Haaga John R | Medical needle with removable sheath |
US4936835A (en) * | 1988-05-26 | 1990-06-26 | Haaga John R | Medical needle with bioabsorbable tip |
US5080655A (en) * | 1988-05-26 | 1992-01-14 | Haaga John R | Medical biopsy needle |
US5053046A (en) * | 1988-08-22 | 1991-10-01 | Woodrow W. Janese | Dural sealing needle and method of use |
US4929246A (en) * | 1988-10-27 | 1990-05-29 | C. R. Bard, Inc. | Method for closing and sealing an artery after removing a catheter |
FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US5007895A (en) * | 1989-04-05 | 1991-04-16 | Burnett George S | Wound packing instrument |
GB8916781D0 (en) | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
US5061274A (en) * | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
US5021059A (en) * | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
EP0476178A1 (en) * | 1990-09-21 | 1992-03-25 | Bioplex Medical B.V. | Device for placing styptic material on perforated blood vessels |
US5391183A (en) * | 1990-09-21 | 1995-02-21 | Datascope Investment Corp | Device and method sealing puncture wounds |
US5192300A (en) * | 1990-10-01 | 1993-03-09 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5108421A (en) * | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5167624A (en) * | 1990-11-09 | 1992-12-01 | Catheter Research, Inc. | Embolus delivery system and method |
US5366480A (en) * | 1990-12-24 | 1994-11-22 | American Cyanamid Company | Synthetic elastomeric buttressing pledget |
US5419765A (en) * | 1990-12-27 | 1995-05-30 | Novoste Corporation | Wound treating device and method for treating wounds |
US5221259A (en) * | 1990-12-27 | 1993-06-22 | Novoste Corporation | Wound treating device and method of using same |
US5310407A (en) * | 1991-06-17 | 1994-05-10 | Datascope Investment Corp. | Laparoscopic hemostat delivery system and method for using said system |
US5163904A (en) * | 1991-11-12 | 1992-11-17 | Merit Medical Systems, Inc. | Syringe apparatus with attached pressure gauge |
US5220926A (en) * | 1992-07-13 | 1993-06-22 | Jones George T | Finger mounted core biopsy guide |
US5413571A (en) * | 1992-07-16 | 1995-05-09 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5483973A (en) * | 1992-10-30 | 1996-01-16 | Becton, Dickinson And Company | Needle stopper and needle removal device |
US5334216A (en) * | 1992-12-10 | 1994-08-02 | Howmedica Inc. | Hemostatic plug |
CN1068230C (en) * | 1993-01-25 | 2001-07-11 | 索纳斯药品有限公司 | Phase shift colloids as ultrasound contrast agents |
US5370656A (en) | 1993-02-26 | 1994-12-06 | Merocel Corporation | Throat pack |
US5322515A (en) | 1993-03-15 | 1994-06-21 | Abbott Laboratories | Luer adapter assembly for emergency syringe |
US5388588A (en) * | 1993-05-04 | 1995-02-14 | Nabai; Hossein | Biopsy wound closure device and method |
US5383896A (en) * | 1993-05-25 | 1995-01-24 | Gershony; Gary | Vascular sealing device |
US5325857A (en) * | 1993-07-09 | 1994-07-05 | Hossein Nabai | Skin biopsy device and method |
US5486195A (en) * | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
US5431639A (en) * | 1993-08-12 | 1995-07-11 | Boston Scientific Corporation | Treating wounds caused by medical procedures |
US5653730A (en) * | 1993-09-28 | 1997-08-05 | Hemodynamics, Inc. | Surface opening adhesive sealer |
US5383899A (en) * | 1993-09-28 | 1995-01-24 | Hammerslag; Julius G. | Method of using a surface opening adhesive sealer |
US5649547A (en) * | 1994-03-24 | 1997-07-22 | Biopsys Medical, Inc. | Methods and devices for automated biopsy and collection of soft tissue |
US5526822A (en) * | 1994-03-24 | 1996-06-18 | Biopsys Medical, Inc. | Method and apparatus for automated biopsy and collection of soft tissue |
US5385550A (en) | 1994-03-29 | 1995-01-31 | Su; Chan-Ho | Needle protective means for prevention against stab and virus infection |
US5545178A (en) * | 1994-04-29 | 1996-08-13 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5522850A (en) * | 1994-06-23 | 1996-06-04 | Incontrol, Inc. | Defibrillation and method for cardioverting a heart and storing related activity data |
JPH10508504A (en) * | 1994-09-16 | 1998-08-25 | バイオプシス メディカル インコーポレイテッド | Method and apparatus for identifying and marking tissue |
US5624402A (en) | 1994-12-12 | 1997-04-29 | Becton, Dickinson And Company | Syringe tip cap |
JPH10512470A (en) * | 1995-01-18 | 1998-12-02 | メドケム プロダクツ,インコーポレーテッド | Apparatus and method for applying a hemostatic agent to tissue |
US6162192A (en) | 1998-05-01 | 2000-12-19 | Sub Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US5645566A (en) * | 1995-09-15 | 1997-07-08 | Sub Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6071300A (en) | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6183497B1 (en) | 1998-05-01 | 2001-02-06 | Sub-Q, Inc. | Absorbable sponge with contrasting agent |
US6071301A (en) | 1998-05-01 | 2000-06-06 | Sub Q., Inc. | Device and method for facilitating hemostasis of a biopsy tract |
US5769086A (en) * | 1995-12-06 | 1998-06-23 | Biopsys Medical, Inc. | Control system and method for automated biopsy device |
US5800389A (en) | 1996-02-09 | 1998-09-01 | Emx, Inc. | Biopsy device |
US5858008A (en) | 1997-04-22 | 1999-01-12 | Becton, Dickinson And Company | Cannula sealing shield assembly |
US5902310A (en) * | 1996-08-12 | 1999-05-11 | Ethicon Endo-Surgery, Inc. | Apparatus and method for marking tissue |
US5810806A (en) * | 1996-08-29 | 1998-09-22 | Ethicon Endo-Surgery | Methods and devices for collection of soft tissue |
US5681279A (en) * | 1996-11-04 | 1997-10-28 | Roper; David H. | Pill dispensing syringe |
US5782861A (en) | 1996-12-23 | 1998-07-21 | Sub Q Inc. | Percutaneous hemostasis device |
US5868762A (en) | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
US6161034A (en) | 1999-02-02 | 2000-12-12 | Senorx, Inc. | Methods and chemical preparations for time-limited marking of biopsy sites |
US6200328B1 (en) | 1998-05-01 | 2001-03-13 | Sub Q, Incorporated | Device and method for facilitating hemostasis of a biopsy tract |
US6315753B1 (en) | 1998-05-01 | 2001-11-13 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
-
1998
- 1998-05-01 US US09/071,670 patent/US6071301A/en not_active Expired - Lifetime
-
1999
- 1999-02-10 US US09/247,880 patent/US6086607A/en not_active Expired - Lifetime
- 1999-04-23 EP EP99922725A patent/EP1075219B8/en not_active Expired - Lifetime
- 1999-04-23 WO PCT/US1999/008907 patent/WO1999056632A1/en active IP Right Grant
- 1999-04-23 JP JP2000546669A patent/JP4139562B2/en not_active Expired - Fee Related
- 1999-04-23 ES ES99922725T patent/ES2270594T3/en not_active Expired - Lifetime
- 1999-04-23 CA CA002330590A patent/CA2330590A1/en not_active Abandoned
- 1999-04-23 AU AU39659/99A patent/AU751444B2/en not_active Ceased
- 1999-04-23 DE DE69932612T patent/DE69932612T2/en not_active Expired - Lifetime
-
2000
- 2000-06-06 US US09/589,036 patent/US6440151B1/en not_active Expired - Lifetime
-
2001
- 2001-09-14 US US09/953,395 patent/US6440153B2/en not_active Expired - Lifetime
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080027389A1 (en) * | 2003-02-12 | 2008-01-31 | Katsuhiro Hiejima | Indwelling catheter |
US7914494B2 (en) * | 2003-02-12 | 2011-03-29 | Nipro Corporation | Indwelling catheter |
US20080187524A1 (en) * | 2003-04-25 | 2008-08-07 | Medtronic Vascular, Inc. | Cellular Therapy to Heal Vascular Tissue |
US20050216018A1 (en) * | 2004-03-29 | 2005-09-29 | Sennett Andrew R | Orthopedic surgery access devices |
US7959634B2 (en) | 2004-03-29 | 2011-06-14 | Soteira Inc. | Orthopedic surgery access devices |
US20070074980A1 (en) * | 2005-09-02 | 2007-04-05 | Bankoski Brian R | Implant rehydration packages and methods of use |
US7909873B2 (en) | 2006-12-15 | 2011-03-22 | Soteira, Inc. | Delivery apparatus and methods for vertebrostenting |
US20100114111A1 (en) * | 2006-12-15 | 2010-05-06 | Francisca Tan-Malecki | Delivery apparatus and methods for vertebrostenting |
US20090326538A1 (en) * | 2006-12-15 | 2009-12-31 | Sennett Andrew R | Devices and methods for fracture reduction |
US20080249481A1 (en) * | 2006-12-15 | 2008-10-09 | Lawrence Crainich | Devices and Methods for Vertebrostenting |
US20080208320A1 (en) * | 2006-12-15 | 2008-08-28 | Francisca Tan-Malecki | Delivery Apparatus and Methods for Vertebrostenting |
US8623025B2 (en) | 2006-12-15 | 2014-01-07 | Gmedelaware 2 Llc | Delivery apparatus and methods for vertebrostenting |
US9192397B2 (en) | 2006-12-15 | 2015-11-24 | Gmedelaware 2 Llc | Devices and methods for fracture reduction |
US9237916B2 (en) | 2006-12-15 | 2016-01-19 | Gmedeleware 2 Llc | Devices and methods for vertebrostenting |
US9480485B2 (en) | 2006-12-15 | 2016-11-01 | Globus Medical, Inc. | Devices and methods for vertebrostenting |
US9687255B2 (en) | 2008-06-17 | 2017-06-27 | Globus Medical, Inc. | Device and methods for fracture reduction |
US10588646B2 (en) | 2008-06-17 | 2020-03-17 | Globus Medical, Inc. | Devices and methods for fracture reduction |
EP2465450A1 (en) * | 2010-12-20 | 2012-06-20 | Tyco Healthcare Group LP | Self Deploying Bodily Opening Protector |
US11865276B2 (en) | 2012-06-15 | 2024-01-09 | W. L. Gore & Associates, Inc. | Vascular occlusion and drug delivery devices, systems, and methods |
Also Published As
Publication number | Publication date |
---|---|
US6071301A (en) | 2000-06-06 |
AU3965999A (en) | 1999-11-23 |
JP2002513609A (en) | 2002-05-14 |
CA2330590A1 (en) | 1999-11-11 |
EP1075219A1 (en) | 2001-02-14 |
AU751444B2 (en) | 2002-08-15 |
DE69932612D1 (en) | 2006-09-14 |
US6086607A (en) | 2000-07-11 |
EP1075219A4 (en) | 2004-07-07 |
US6440151B1 (en) | 2002-08-27 |
JP4139562B2 (en) | 2008-08-27 |
WO1999056632A1 (en) | 1999-11-11 |
US6440153B2 (en) | 2002-08-27 |
EP1075219B1 (en) | 2006-08-02 |
EP1075219B8 (en) | 2006-10-18 |
ES2270594T3 (en) | 2007-04-01 |
DE69932612T2 (en) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6086607A (en) | Device and method for facilitating hemostasis of a biopsy tract | |
US6200328B1 (en) | Device and method for facilitating hemostasis of a biopsy tract | |
US8050741B2 (en) | Device and method for facilitating hemostasis of a biopsy tract | |
US7753872B2 (en) | Device, system and method for improving delivery of hemostatic material | |
US6610026B2 (en) | Method of hydrating a sponge material for delivery to a body | |
US6315753B1 (en) | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC CORPORATION, MASSACHUSETTS Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: PACIFIC VENTURE GROUP II, L.P., CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: PVG ASSOCIATES II, L.P., CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: PEQUOT PRIVATE EQUITY FUND II, L.P., CONNECTICUT Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: KINGSBURY CAPITAL PARTNERS, L.P. III, CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: KINGSBURY CAPITAL PARTNERS, L.P. IV, CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: HARTZLER, GEOFFREY O., KANSAS Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: WALLACE, GEORGE, CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: CRAGG, ANDREW H., MINNESOTA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: ALLEN FAMILY TRUST DATED 10/12/81, CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: FEUCHTER, BRUCE, CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: BOSTON SCIENTIFIC CORPORATION,MASSACHUSETTS Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: PACIFIC VENTURE GROUP II, L.P.,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: PVG ASSOCIATES II, L.P.,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: PEQUOT PRIVATE EQUITY FUND II, L.P.,CONNECTICUT Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: KINGSBURY CAPITAL PARTNERS, L.P. III,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: KINGSBURY CAPITAL PARTNERS, L.P. IV,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: HARTZLER, GEOFFREY O.,KANSAS Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: WALLACE, GEORGE,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: CRAGG, ANDREW H.,MINNESOTA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: ALLEN FAMILY TRUST DATED 10/12/81,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 Owner name: FEUCHTER, BRUCE,CALIFORNIA Free format text: NOTE AND WARRANT PURCHASE AGREEMENT;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:015156/0484 Effective date: 20040831 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:018420/0029 Effective date: 20050504 Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUB-Q, INC.;REEL/FRAME:018420/0029 Effective date: 20050504 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |